CodeSystem |
https://ncez.mzcr.cz/fhir/CodeSystem/registering-provider-service-type-cz-cs  | Registering Provider Service Type Cz |
https://smartforms.csiro.au/ig/CodeSystem/HealthChecksSCTSupplement  | SNOMED CT Supplement for Aboriginal and Torres Strait Islander Health Check |
http://ehealth.sundhed.dk/snomed.info/sct/supplement  | SNOMED CT Code System Supplement |
https://demis.rki.de/fhir/CodeSystem/translationEvidence  | Übersetzung Symptom und Manifestation |
https://www.medizininformatik-initiative.de/fhir/core/modul-diagnose/CodeSystem/mii-cs-diagnose-lebensphase-supplement-snomed  | MII_CS_Diagnose_Lebensphase_Supplement_SNOMED |
https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/snomed-pce-supplement  | SNOMED Supplement CodeSystem |
http://hl7.org/fhir/us/davinci-hrex/ConceptMap/CareTeamMember-NUCCFunction  | SNOMED Care Team Member Function to NUCC Map |
http://hl7.org/fhir/us/davinci-hrex/ConceptMap/NUCC-CareTeamMemberFunction  | NUCC to SNOMED Care Team Member Function Map |
http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsDevice  | Vitals Device used to SNOMED code |
http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsLaterality  | Vitals Laterality used to SNOMED code |
http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsMethod  | Vitals Method used to SNOMED code |
http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsPosition  | Vitals Position used to SNOMED code |
http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsSite  | Vitals Site used to SNOMED code |
https://www.ehealth.fgov.be/standards/fhir/mycarenet/ConceptMap/BeCMISOToothSnomedCT  | BeCMISOToothSnomedCT |
http://hl7.org/fhir/us/vrdr/ConceptMap/CertifierTypesCM  | CertifierTypes Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/ContributoryTobaccoUseCM  | ContributoryTobaccoUse Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/MannerOfDeathCM  | MannerOfDeath Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/MethodOfDispositionCM  | MethodOfDisposition Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/PlaceOfDeathCM  | PlaceOfDeath Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/TransportationIncidentRoleCM  | TransportationIncidentRole Concept Map |
http://fhir.ch/ig/ch-term/ConceptMap/DocumentEntryClassCodeToDocumentEntryTypeCode  | DocumentEntryClassCodeToDocumentEntryTypeCode |
http://fhir.ch/ig/ch-term/ConceptMap/HCProfessionalHCProfessionSpecialisationMap  | HCProfessionalHCProfessionSpecialisationMap |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-targetdiseases-vaccines-cm  | TargetDisease To VaccineCode Mapping |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-sct-sm-cm  | Snomed CT VaccineCode To SwissMedic VaccineCode |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-sct-targetdiseases-cm  | Snomed CT VaccineCode To TargetDisease Mapping |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-sm-sct-cm  | SwissMedic VaccineCode To Snomed CT VaccineCode |
http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-targetdiseases-cm  | VaccineCode To TargetDisease Mapping |
http://fhir.ch/ig/ch-core/ConceptMap/documententry-confidentialitycode-to-fhir  | DocumentEntry.confidentialityCode to FHIR mapping |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapBirthAttendantTitlesVitalRecords  | BirthAttendantTitles Concept Map |
http://hl7.org/fhir/us/mcode/ConceptMap/TG263CM  | TG263 Concept Map |
http://fhir.ch/ig/ch-elm/ConceptMap/ch-elm-results-to-foph-patient-name-representation  | CH ELM Results To FOPH Patient Name Representation |
http://fhir.ch/ig/ch-elm/ConceptMap/ch-elm-results-to-interpretation-code  | CH ELM Results To Interpretation Code |
http://fhir.org/guides/who/anc-cds/ConceptMap/SNOMED-CT  | SNOMED-CT |
https://twcore.mohw.gov.tw/ig/pas/ConceptMap/nhi-sct-body-site  | 臺灣健保署身體部位代碼對應SNOMED CT |
http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-do-missing-measurement  | Activitydefinition-code to do missing measurement |
http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-do-reminder  | Activitydefinition-code to do reminder |
http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-measurement-resource-type  | Activitydefinition-code to measurement resource type |
http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-perform-sharing  | Activitydefinition-code-to-perform-sharing |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-AllergyIntoleranceCategory  | CCDA to FHIR Allergy Intolerance Category |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-AllergyIntoleranceType  | CCDA to FHIR Allergy Intolerance Type |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-AllergyStatus  | C-CDA to FHIR Allergy Status |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-NoKnownAllergies  | C-CDA to FHIR No Known Allergies |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-ProblemStatus  | C-CDA Problem Status value to FHIR Condition clinicalStatus |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-Severity  | C-CDA Severity to FHIR Severity |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-AllergyIntoleranceCategory  | FHIR to CCDA Allergy Intolerance Category |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-AllergyIntoleranceType  | FHIR Allergy Intolerance Type to CCDA value |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-AllergyStatus  | FHIR to C-CDA Allergy Status |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-ImmunizationRefusal  | FHIR Immunization Status Reason to C-CDA Immunization Refusal |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-ImmunizationSite  | FHIR Immunization Site to C-CDA Immunization approachSiteCode |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-NoKnownAllergies  | FHIR to C-CDA No Known Allergies |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-ProblemStatus  | FHIR Condition clinicalStatus to C-CDA Problem Status value |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-Severity  | FHIR Severity to C-CDA Severity |
http://smart.who.int/ddcc/ConceptMap/lab-test-pathogen-snomed-to-icd11  | Lab Test - Result - Pathogen - Mapping SNOMED CT to ICD-11 |
http://smart.who.int/ddcc/ConceptMap/lab-test-qual-result-snomed-to-icd11  | Lab Test - Result - Mapping SNOMED CT to ICD-11 |
http://smart.who.int/ddcc/ConceptMap/vaccine-covid19-snomed-to-icd11  | Vaccine - COVID-19 - Mapping SNOMED to ICD-11 |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-agent-targeted  | ConceptMap from ICD-11 to SNOMED CT for Agent Targeted |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-disease-targeted  | ConceptMap from ICD-11 to SNOMED CT for Disease or Agent Targeted |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-test-result  | ConceptMap from ICD-11 to SNOMED CT for Test Result |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-vaccines  | ConceptMap from ICD-11 to SNOMED CT for Vaccines |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-ichi-sct-specimen-origin  | ConceptMap from ICHI to SNOMED CT for Specimen Origin |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-ichi-sct-type-of-test  | ConceptMap from ICHI to SNOMED CT for Type of Test |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-loinc-sct-type-of-test  | ConceptMap from LOINC to SNOMED CT for Type of Test |
http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-sct-ichi-specimen-origin  | ConceptMap from SNOMED CT to ICHI for Specimen Origin |
http://hl7.org/fhir/us/davinci-alerts/ConceptMap/direct-alerts  | Direct ADT to Da Vinci Alerts ConceptMap |
https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/health-professional-tw  | 臺灣醫事司醫事人員類別代碼對應SNOMED CT及臺灣醫事司醫事人員類別 |
https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/medical-consultation-department-nhi-tw  | 臺灣健保署就醫科別代碼對應SNOMED CT |
https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/medical-treatment-department-nhi-tw  | 臺灣健保署診療科別代碼對應SNOMED CT |
https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/medication-path-tw  | 臺灣健保署給藥途徑代碼對應SNOMED CT |
http://hl7.org/fhir/us/bfdr/ConceptMap/BirthAttendantTitlesCM  | BirthAttendantTitles Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/BirthDeliveryOccurredCM  | BirthDeliveryOccurred Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/DeliveryRoutesCM  | DeliveryRoutes Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/FetalDeathCauseOrConditionCM  | FetalDeathCauseOrCondition Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/FetalDeathTimePointsCM  | FetalDeathTimePoints Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/FetalPresentationCM  | FetalPresentation Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/InfectionsDuringPregnancyLiveBirthCM  | InfectionsDuringPregnancyLiveBirth Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/NewbornCongenitalAnomaliesCM  | NewbornCongenitalAnomalies Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/PerformedNotPerformedPlannedCM  | PerformedNotPerformedPlanned Concept Map |
http://fhir.hl7.nl/zorgviewer/ConceptMap/epic-rolcode  | Epic Provider Type naar SNOMED-CT Mapping |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_DPE_Declaration_Type_German  | Art der Erklärung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Implant_German  | Medizinprodukt |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Person_Institution_German  | BAI_ART |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Procedure_German  | Prozedur SNOMEDCT |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Reaction_Allergy_German  | Allergie Manifestation |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Runaway_Risk_German  | Weglaufgefährdung |
https://fhir.cohesiondata.com/clinemr/ConceptMap/treatment-region-tw  | 臺灣診療部位代碼對應SNOMED CT |
https://fhir.ee/ConceptMap/person-relationship-mpi-v3  | Mapping of MPI person relationship to legacy V3 |
https://fhir.ee/ConceptMap/person-relationship-v3-mpi  | Mapping of legacy V3 person relationship to MPI |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Terminology_Complete_German  | KBV_CM_Base_Terminology_Complete_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Apgar_Score_Identifier_German  | KBV_CM_Base_Apgar_Score_Identifier_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Apgar_Score_Value_German  | KBV_CM_Base_Apgar_Score_Value_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Body_Height_Snomed_German  | KBV_CM_Base_Body_Height_Snomed_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Body_Weight_Method_Snomed_German  | KBV_CM_Base_Body_Weight_Method_Snomed_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Body_Weight_Snomed_German  | KBV_CM_Base_Body_Weight_Snomed_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Diagnosis_Severity_German  | KBV_CM_Base_Diagnosis_Severity_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Head_Circumference_BodySite_Snomed_German  | KBV_CM_Base_Head_Circumference_BodySite_Snomed_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Head_Circumference_Snomed_German  | KBV_CM_Base_Head_Circumference_Snomed_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Practitioner_Function_German  | KBV_CM_Base_Practitioner_Function_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Stage_Life_German  | KBV_CM_Base_Stage_Life_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Body_Temp_Snomed_German  | KBV_CM_Base_Body_Temp_Snomed_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Heart_Rate_German  | KBV_CM_Base_Heart_Rate_German |
http://fhir.tasmc.org.il/ConceptMap/tasmc-snomedct-specimen-type  | Mapping from Sourasky local specimen types to SNOMED CT |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_LAB_ELGA_Specimen_Type_SNOMED_German  | ELGA Probenart SNOMED |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_IHEXDS_AuthorSpeciality_Restricted_German  | KBV_CM_MIO_Vaccination_IHEXDS_AuthorSpeciality_Restricted_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_German  | KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_LOINC_Snomed  | KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_LOINC_Snomed |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Lab_Titer_Immunity_German  | Titer Immunität |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Prior_Disease_German  | VaccinationrelevantDisease |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Prior_Disease_Snomed_ICD  | KBV_CM_MIO_Vaccination_Prior_Disease_Snomed_ICD |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Source_of_Information_German  | Source_of_Information |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Vaccine_ATC_Snomed  | KBV_CM_MIO_Vaccination_Vaccine_ATC_Snomed |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Vaccine_German  | Vaccine |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Vaccine_Targetdisease  | KBV_CM_MIO_Vaccination_Vaccine_Targetdisease |
http://nictiz.nl/fhir/ConceptMap/Alcoholgebruik-to-AlcoholGebruikStatusCodelijst  | Alcoholgebruik-to-AlcoholGebruikStatusCodelijst |
http://nictiz.nl/fhir/ConceptMap/Rookgedrag-to-TabakGebruikStatusCodelijst  | Rookgedrag-to-TabakGebruikStatusCodelijst |
http://nictiz.nl/fhir/ConceptMap/WerkelijkePlaatsBaring-to-ActEncounterCode  | WerkelijkePlaatsBaring-to-ActEncounterCode |
http://fhir.ch/ig/ch-emed-epr/ConceptMap/CHEMEDEPRAmountQuantityUnitCodeToCdTyp9  | CHEMEDEPRAmountQuantityUnitCode -> CdTyp9 |
http://fhir.ch/ig/ch-emed-epr/ConceptMap/CdTyp9ToCHEMEDEPRAmountQuantityUnitCode  | CdTyp9 -> CHEMEDEPRAmountQuantityUnitCode |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_AB0_System_First_Examination_After_Childbirth_German  | AB0-System des Kindes im Wochenbett |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_AB0_System_German  | AB0-System |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Biometrics_II_III_German  | Biometrie II und III |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Biometrics_I_German  | Biometrie I |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Birth_Mode_German  | Geburtsmodus |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Breastfeeding_Behavior_German  | Stillverhalten der Mutter |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Catalogue_A_German  | Anamneseerhebung bei Erstuntersuchung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Child_Position_German  | Kindslage |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Counselling_German  | Beratung von Schwangeren |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Direct_Coombstest_German  | Direkter Coombstest |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Examination_Interpretation_German  | Interpretation der Messergebnisse hinsichtlich der Immunität |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Examination_Result_Qualitative_German  | Qualitative Beurteilung der Messergebnisse |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Examination_Snomed_German  | Laboruntersuchungen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Findings_Required_Control_German  | Kontrollbedürftige Befunde |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_General_Information_German  | Allgemeine Angaben zum Fötus beim ersten Ultraschallscreening |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Heart_Sounds_Child_German  | Herztöne des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Immunization_Status_German  | Nachweise der prophylaktischen Impfungen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Localisation_Placenta_German  | Lokalisation/Struktur der Plazenta |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Morphology_German  | Morphologie |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Other_Ultrasound_Studies_German  | Weitere Ultraschalluntersuchungen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Practitioner_Function_German  | Funktionen/Rollen des Behandelnden |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Pregnancy_Information_German  | Angaben zur Schwangerschaft beim Ultraschallscreening |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Rhesus_System_Fetus_German  | Rhesus-System des Fötus |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Rhesus_System_German  | Rhesus-System |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Special_Findings_German  | Befundkatalog Besondere Befunde |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_oGTT_Diagnosistest_German  | Oraler Glucosetoleranztest (oGTT) Diagnosetest |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_oGTT_Pretest_German  | Oraler Glucosetoleranztest (oGTT) Vortest |
https://fhir.hl7.org.uk/STU3/ConceptMap/CareConnect-AllergySeverity-1  | Concept Map - Allergy Severity |
https://fhir.hl7.org.uk/STU3/ConceptMap/CareConnect-AllergyVerificationStatus-1  | Concept Map - Allergy Verification Status |
https://fhir.hl7.org.uk/STU3/ConceptMap/CareConnect-ConditionEpisodicity-1  | Concept Map - Condition Episodicity |
https://demis.rki.de/fhir/ConceptMap/LOINCMaterialToSNOMEDMaterial  | LOINCMaterialToSNOMEDMaterial |
https://demis.rki.de/fhir/ConceptMap/LOINCMethodToSNOMEDMethod  | LOINCMethodToSNOMEDMethod |
http://nictiz.nl/fhir/ConceptMap/AllergieCategorieCodelijst-to-AllergyIntoleranceCategory  | AllergieCategorieCodelijst to AllergyIntoleranceCategory |
http://nictiz.nl/fhir/ConceptMap/ErnstCodelijst-to-AllergyIntoleranceSeverity  | ErnstCodelijst to AllergyIntoleranceSeverity |
http://nictiz.nl/fhir/ConceptMap/InterpretatieVlaggenCodelijst-to-ObservationInterpretationCodes  | InterpretatieVlaggenCodelijst to ObservationInterpretationCodes |
http://nictiz.nl/fhir/ConceptMap/MateVanKritiekZijnCodelijst-to-AllergyIntoleranceCriticality  | MateVanKritiekZijnCodelijst to AllergyIntoleranceCriticality |
http://nictiz.nl/fhir/ConceptMap/ProbleemStatusCodelijst-to-ConditionClinicalStatusCodes  | ProbleemStatusCodelijst to ConditionClinicalStatusCodes |
http://nictiz.nl/fhir/ConceptMap/VerificatieStatusCodelijst-to-ConditionVerificationStatus  | VerificatieStatusCodelijst to ConditionVerificationStatus |
https://fhir.nhs.uk/STU3/ConceptMap/CareConnect-AllergySeverity-1  | Concept Map - Allergy Severity |
https://fhir.nhs.uk/STU3/ConceptMap/CareConnect-AllergyVerificationStatus-1  | Concept Map - Allergy Verification Status |
https://www.medizininformatik-initiative.de/fhir/ext/modul-biobank/ConceptMap/SPRECFixationTypeMap  | SPREC 3.0 Fixation Type Mapping |
https://www.medizininformatik-initiative.de/fhir/ext/modul-biobank/ConceptMap/SPRECLongTermStorageMap  | SPREC 3.0 Long-Term Storage Mapping |
https://www.medizininformatik-initiative.de/fhir/ext/modul-biobank/ConceptMap/SPRECPrimaryContainerMap  | SPREC 3.0 Primary Container Mapping |
https://www.medizininformatik-initiative.de/fhir/ext/modul-biobank/ConceptMap/SPRECSampleTypeMap  | SPREC 3.0 Sample Type Mapping |
https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/ConceptMap/mii-cm-mtb-therapiestatusgrund-sct  | MII CM MTB Therapiestatusgrund SNOMED CT Mapping |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_ULB_Overview  | KBV_CM_MIO_ULB_Overview |
http://ig.ehealth4u.eu/fhir/ConceptMap/cyehr-cm-allergyreactionseverity-snomed2hl7fhir  | Cyprus EHR Concept Map: Allergy Reaction Severity - Snomed to HL7 FHIR |
http://ig.ehealth4u.eu/fhir/ConceptMap/cyehr-cm-allergytype-snomed2hl7fhir  | Cyprus EHR Concept Map: Allergy Type - Snomed to HL7 FHIR |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Bodysite_Hip_German  | Hüftlateralität |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Examination_Number_German  | Untersuchungsnummer U-Heft |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Foetal_Position_German  | Kindslage aus Sicht d. Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Gender_Birth_German  | Geschlecht SNOMED |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hearscreening_Method_German  | Hörscreenigmethode |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hearscreening_Result_German  | Hörscreeningbefund Lokalisation |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hip_History_German  | Hüftanamnese |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hip_Proceeding_German  | Hüfte - weiteres Vorgehen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hip_Screening_Method_German  | Hüftscreening Methode |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Newborn_Blood_Spot_Screening_Type_German  | Typ der Blutabnahme |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Percentile_Body_Measure_Loinc_German  | Perzentilkörpermaß LOINC |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Percentile_Body_Measure_Snomed_German  | Perzentilkörpermaß SNOMED |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Practitioner_Speciality_German  | Rolle des Behandelnden |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Pregnancy_History_German  | Schwangerschaftsanamnese |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Pulse_Oxymetry_Screening_Data_Absent_Reason_German  | Gründe zur Ablehnung des Pulsoxymetriescreenings |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Pulse_Oxymetry_Screening_Measurement_Type_German  | Typ der Pulsoxymetriemessung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U1_Apgar_Score_Identifier_German  | Apgar Score am Zeitpunkt |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U1_Apgar_Score_Value_German  | Apgar-Score Wert |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U1_U3_Birthmode_German  | Geburtsmodus |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U1_U3_Pulse_Oxymetry_Measurement_German  | Auffälligkeit Sauerstoffsättigung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Consultation_German  | U2 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Current_Child_History_German  | U2 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Family_History_German  | U2 - Familienanamnese |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Physical_Exam_Head_German  | U2 - Kopf |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Physical_Exam_Mouth_Nose_German  | U2 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Physical_Exam_Musculoskeletal_System_German  | U2 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Physical_Exam_Skin_German  | U2 - Haut |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U3_Physical_Exam_Abdomen_Genitals_German  | U2, U3 - Abdomen, Genitale |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U3_Physical_Exam_Ears_German  | U2, U3 - Ohren |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U3_Physical_Exam_Eyes_German  | U2, U3 - Augen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U4_Physical_Exam_Chest_Lung_Respiratory_Tract_German  | U2, U3, U4 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U6_Physical_Exam_Heart_Blood_Circulation_German  | U2, U3, U4, U5, U6 - Herz, Kreislauf |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Consultation_German  | U3 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Current_Child_History_German  | U3 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Development_Assessment_German  | U3 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Family_History_German  | U3 - Familienanamnese |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Physical_Exam_Head_German  | U3 - Kopf |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Physical_Exam_Musculoskeletal_System_German  | U3 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_U4_Physical_Exam_Mouth_Nose_German  | U3, U4 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_U4_Physical_Exam_Skin_German  | U3, U4 - Haut |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_U9_Age_Appropriate_Development_German  | altersgemäße Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_U9_Social_History_German  | U3-U9 - Sozialanamnese |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Consultation_German  | U4 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Current_Child_History_German  | U4 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Development_Assessment_German  | U4 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Physical_Exam_Abdomen_Genitals_German  | U4 - Abdomen, Genitale |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Physical_Exam_Head_German  | U4 - Kopf |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Physical_Exam_Musculoskeletal_System_German  | U4 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_U5_Physical_Exam_Eyes_German  | U4, U5 - Augen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Consultation_German  | U5 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Current_Child_History_German  | U5 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Development_Assessment_German  | U5 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Physical_Exam_Chest_Lung_Respiratory_Tract_German  | U5 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Physical_Exam_Mouth_Nose_German  | U5 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Physical_Exam_Musculoskeletal_System_German  | U5 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_U6_Physical_Exam_Abdomen_Genitals_German  | U5, U6 - Abdomen, Genitale |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_U6_Physical_Exam_Head_German  | U5, U6 - Kopf |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_U9_Physical_Exam_Skin_German  | U5, U6, U7, U7a, U8, U9 - Haut |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Consultation_German  | U6 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Current_Child_History_German  | U6 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Development_Assessment_German  | U6 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Physical_Exam_Eyes_German  | U6 - Augen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Physical_Exam_Mouth_Nose_German  | U6 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Physical_Exam_Musculoskeletal_System_German  | U6 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_U7_Physical_Exam_Chest_Lung_Respiratory_Tract_German  | U6, U7 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Consultation_German  | U7 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Current_Child_History_German  | U7 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Development_Assessment_German  | U7 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Physical_Exam_Eyes_German  | U7 - Augen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Physical_Exam_Mouth_Nose_German  | U7 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Physical_Exam_Musculoskeletal_System_German  | U7 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_U7a_Physical_Exam_Abdomen_Genitals_German  | U7, U7a - Abdomen, Genitale |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_U9_Physical_Exam_Heart_Blood_Circulation_German  | U7, U7a, U8, U9 - Herz, Kreislauf |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_Consultation_German  | U7a - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_Current_Child_History_German  | U7a - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_Development_Assessment_German  | U7a - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_Physical_Exam_Mouth_Nose_German  | U7a - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_U9_Physical_Exam_Eyes_German  | U7a, U8, U9 - Augen |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_and_U9_Physical_Exam_Chest_Lung_Respiratory_Tract_German  | U7a, U9 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_and_U9_Physical_Exam_Musculoskeletal_System_German  | U7a, U9 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Consultation_German  | U8 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Current_Child_History_German  | U8 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Development_Assessment_German  | U8 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Physical_Exam_Abdomen_Genitals_German  | U8 - Abdomen, Genitale |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Physical_Exam_Chest_Lung_Respiratory_Tract_German  | U8 - Thorax, Lunge, Atemwege |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Physical_Exam_Ears_German  | U8 - Ohren |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Physical_Exam_Musculoskeletal_System_German  | U7a, U9 - Bewegungsapparat |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_U9_Physical_Exam_Mouth_Nose_German  | U8, U9 - Mundhöhle, Kiefer, Nase |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U9_Consultation_German  | U9 - Beratung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U9_Current_Child_History_German  | U9 - Aktuelle Anamnese des Kindes |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U9_Development_Assessment_German  | U9 - Orient. Beurt. Entwicklung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U9_Physical_Exam_Abdomen_Genitals_German  | U9 - Abdomen, Genitale |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_PC_PN_Examination_Number_German  | Untersuchungsnummer Teilnahmekarte |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_EMP_Overview  | KBV_CM_MIO_EMP_Overview |
http://hitstdio.ntunhs.edu.tw/fhir/ConceptMap/TWCDCVaccineCodeToQRCodeSctVaccinesCovid19  | TWCDC Vaccine Code to QRCode Sct Vaccines Covid-19 |
http://nictiz.nl/fhir/ConceptMap/DagdeelCodelijst-to-EventTiming  | DagdeelCodelijst to EventTiming |
http://nictiz.nl/fhir/ConceptMap/WeekdagCodelijst-to-DaysOfWeek  | WeekdagCodelijst to DaysOfWeek |
https://fhir.kbv.de/KBV_CM_MIO_CMR_U7a_Current_Child_History_German  | U7a - Aktuelle Anamnese des Kindes |
https://fhir.nhs.uk/ConceptMap/genomics-laterality-of-hearingloss  | Genomics Laterality of Hearing Loss |
https://fhir.nhs.uk/ConceptMap/genomics-condition-liquidtumourtype  | Genomics Condition Liquid Tumour Type |
https://fhir.nhs.uk/ConceptMap/genomics-condition-pancreatictumourtype  | Genomics Condition Pancreatic Tumour Type |
https://fhir.nhs.uk/ConceptMap/genomics-condition-pituitarytumourtype  | Genomics Condition Pituitary Tumour Type |
https://fhir.nhs.uk/ConceptMap/genomics-condition-solidtumourtype  | Genomics Condition Solid Tumour Type |
https://fhir.nhs.uk/ConceptMap/genomics-fetal-maternal-screening-genotype  | Genomics Fetal Maternal Screening Genotype |
https://fhir.nhs.uk/ConceptMap/genomics-patientpregnancytype  | Genomics Patient Pregnancy Type |
https://fhir.nhs.uk/ConceptMap/genomics-procedure-transfusiontype  | Genomics Procedure Transfusion Type |
https://fhir.nhs.uk/ConceptMap/genomics-risk-reason-for-specimen-specialhandling  | Genomics Risk Reason for Specimen Special Handling |
https://fhir.nhs.uk/ConceptMap/genomics-finalsample  | Genomics Final Sample |
https://fhir.nhs.uk/ConceptMap/genomics-primarysample  | Genomics Primary Sample |
https://fhir.nhs.uk/ConceptMap/genomics-samplepreparation  | Genomics Sample Preparation |
https://fhir.nhs.uk/ConceptMap/genomics-specimen-tumourcellularity  | Genomics Specimen Tumour Cellularity |
https://fhir.nhs.uk/ConceptMap/genomics-typeof-transplantprocedure  | Genomics Type of Transplant Procedure |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_ZAEB_Preventive_Check_Up_German  | KBV_CM_MIO_ZAEB_Preventive_Check_Up_German |
https://fhir.healthdata.be/ConceptMap/AllergyCategory-to-AllergyIntoleranceCategory  | AllergyCategory_to_AllergyIntoleranceCategory |
https://fhir.healthdata.be/ConceptMap/AllergyStatus-to-AllergyIntoleranceClinicalStatusCodes  | AllergyStatus_to_AllergyIntoleranceClinicalStatusCodes |
https://fhir.healthdata.be/ConceptMap/ContactType-to-ActEncounterCode  | ContactType to ActEncounterCode |
https://fhir.healthdata.be/ConceptMap/CriticalExtent-to-AllergyIntoleranceCriticality  | CriticalExtent_to_AllergyIntoleranceCriticality |
https://fhir.healthdata.be/ConceptMap/CriticalExtent-to-AllergyIntoleranceSeverity  | CriticalExtent_to_AllergyIntoleranceSeverity |
https://fhir.healthdata.be/ConceptMap/Gender-to-AdministrativeGender  | Gender_to_AdministrativeGender |
https://fhir.healthdata.be/ConceptMap/MedicationAdministrationStatus-to-MedicationAdministrationStatus  | MedicationAdministrationStatus_to_MedicationAdministrationStatusCodes |
https://fhir.healthdata.be/ConceptMap/MedicationStopType-to-MedicationStatementStatus  | MedicationStopType_to_MedicationStatementStatus |
https://fhir.healthdata.be/ConceptMap/NameUsage-to-HumanNameAssemblyOrder  | NameUsage_to_HumanNameAssemblyOrder |
https://fhir.healthdata.be/ConceptMap/ProblemStatus-to-ConditionClinicalStatusCodes  | ProblemStatus_to_ConditionClinicalStatusCodes |
https://fhir.healthdata.be/ConceptMap/ResultFlags-to-ObservationInterpretationCodes  | ResultFlags_to_ObservationInterpretationCodes |
https://fhir.healthdata.be/ConceptMap/TimeOfDay-to-EventTiming  | TimeOfDay_to_EventTiming |
https://fhir.healthdata.be/ConceptMap/TreatmentDecision-to-ConsentProvisionType  | TreatmentDecision to ConsentProvisionType |
https://fhir.healthdata.be/ConceptMap/VerificationStatus-to-ConditionVerificationStatus  | VerificationStatus_to_ConditionVerificationStatus |
https://fhir.healthdata.be/ConceptMap/WeekDay-to-DaysOfWeek  | WeekDay_to_DaysOfWeek |
http://hl7.org/fhir/uv/ips/ConceptMap/absence-to-snomed-uv-ips  | Absence of Information Mappings - IPS to SNOMED CT |
http://hl7.org/fhir/uv/ips/ConceptMap/severity-snomedct-uv-ips  | Severity Value Set Mappings - SNOMED CT to FHIR |
http://fhir.ch/ig/ch-epr-term/ConceptMap/DocumentEntryClassCodeToDocumentEntryTypeCode  | DocumentEntryClassCodeToDocumentEntryTypeCode |
http://fhir.ch/ig/ch-epr-term/ConceptMap/HCProfessionalHCProfessionSpecialisationMap  | HCProfessionalHCProfessionSpecialisationMap |
http://fhir.nottinghamshire.gov.uk/conceptmap/rockwood-clinical-frailty-scale  | Concept Map Rockwood Clinical Frailty Scale |
http://nictiz.nl/fhir/ConceptMap/MateVanKritiekZijnCodelijst-to-allergy-intolerance-criticality  | HCIM MateVanKritiekZijnCodelijst to allergy-intolerance-criticality |
http://nictiz.nl/fhir/ConceptMap/ProbleemStatusCodelijst-to-Condition-Clinical-Status-Codes  | HCIM ProbleemStatusCodelijst to Condition Clinical Status Codes |
http://nictiz.nl/fhir/ConceptMap/WaarschijnlijkheidCodelijst-to-reaction-event-certainty  | HCIM WaarschijnlijkheidCodelijst to reaction-event-certainty |
http://nictiz.nl/fhir/ConceptMap/AllergieCategorieCodelijst-to-allergy-intolerance-category  | HCIM AllergieCategorieCodelijst to allergy intolerance category |
http://nictiz.nl/fhir/ConceptMap/Condition-Clinical-Status-Codes-to-ProbleemStatusCodelijst  | HCIM ProbleemStatusCodelijst to Condition Clinical Status Codes |
http://nictiz.nl/fhir/ConceptMap/InterpretatieVlaggenCodelijst-to-observation-interpretation  | HCIM InterpretatieVlaggenCodelijst to Observation Interpretation Codes |
http://nictiz.nl/fhir/ConceptMap/OrderStatusCodelijst-to-RequestStatus  | HCIM OrderStatusCodelijst to RequestStatus |
http://nictiz.nl/fhir/ConceptMap/PositieCodelijst-to-LOINC  | HCIM PositieCodelijst to LOINC |
http://nictiz.nl/fhir/ConceptMap/WeekdagCodelijst-to-days-of-week  | HCIM WeekdagCodelijst-to-days-of-week |
https://mednet.swiss/fhir/ConceptMap/mni-obs-bloodGroup-toSnomed  | MedNet Interface (MNI) - Blood Group Observation SNOMED Mapping |
http://nictiz.nl/fhir/ConceptMap/CategorieCodelijst-to-AllergyIntoleranceCategory  | CategorieCodelijst to AllergyIntoleranceCategory |
http://nictiz.nl/fhir/ConceptMap/VerwachtRisicoBijBlootstelling-to-AllergyIntoleranceCriticality  | VerwachtRisicoBijBlootstelling to AllergyIntoleranceCriticality |
http://portal.esysta.com/fhir/ConceptMap/EvaluationItem  | Mapping of EvaluationItem to SNOMED CT |
http://portal.esysta.com/fhir/ConceptMap/EvaluationItemToSnomedCM  | Mapping of EvaluationItemCS to SNOMED CT |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Clinical_Course_German  | KBV_CM_MIO_TELE_Clinical_Course_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Procedure_And_Recommendations_German  | Weiteres Procedere und Empfehlung |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Procedure_Category_Codes_SNOMEDCT_German  | KBV_CM_MIO_TELE_Procedure_Category_Codes_SNOMEDCT_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Procedure_Follow_Up_Codes_SNOMEDCT_German  | KBV_CM_MIO_TELE_Procedure_Follow_Up_Codes_SNOMEDCT_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Results_Type_German  | KBV_CM_MIO_TELE_Results_Type_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_SNOMED_CT_Drug_Therapy_Status_Codes_German  | KBV_CM_MIO_TELE_SNOMED_CT_Drug_Therapy_Status_Codes_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Type_Of_Medical_History_German  | KBV_CM_MIO_TELE_Type_Of_Medical_History_German |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_KHE_Overview  | KBV_CM_MIO_KHE_Overview |
https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_DIGA_Overview  | KBV_CM_MIO_DIGA_Overview |
https://hl7.cz/fhir/img-order/StructureDefinition/DataElementsImageOrderCz  | Data elements about order: Imaging Order (CZ) |
http://nrces.in/ndhm/fhir/r4/StructureDefinition/MedicationRequest  | MedicationRequest |
https://fhir.hl7.org.uk/STU3/StructureDefinition/CareConnect-ACVPU-Observation-1  | CareConnect-ACVPU-Observation-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-ApplianceUseReview-Composition-1  | CareConnect-ITK-DM-ApplianceUseReview-Composition-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-DMIRS-Composition-1  | CareConnect-ITK-DM-DMIRS-Composition-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-EmergencySupply-Composition-1  | CareConnect-ITK-DM-EmergencySupply-Composition-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-Immunization-Composition-1  | CareConnect-ITK-DM-Immunization-Composition-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-MedicationReview-Composition-1  | CareConnect-ITK-DM-MedicationReview-Composition-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-NewMedicineService-Composition-1  | CareConnect-ITK-DM-NewMedicineService-Composition-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-ECD-Composition-1  | Electronic Discharge Composition |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-EDIS-Composition-1  | Electronic Discharge Composition |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-MH-Composition-1  | Mental Health Electronic Discharge Composition |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-OPL-Composition-1  | Outpatient Letter Composition |
https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-NEWS2-Observation-1  | CareConnect-NEWS2-Observation-1 |
https://fhir.nhs.uk/STU3/StructureDefinition/NDOP-Consent-1  | NDOP-Consent-1.xml |
https://fhir.nhs.uk/STU3/StructureDefinition/eRS-ServiceSearchCriteria-Parameters-1  | eRS-ServiceSearchCriteria-Parameters-1 |
https://emiga.rki.de/fhir/case/StructureDefinition/CaseComposition  | Fall |
http://hl7.org/fhir/StructureDefinition/patient-adoptionInfo  | Patient Adoption Info |
http://ontariohealth.ca/fhir/StructureDefinition/ca-on-accdr-profile-AllergyIntolerance  | AllergyIntolerance Profile |
https://nrces.in/ndhm/fhir/r4/StructureDefinition/MedicationRequest  | MedicationRequest |
http://capable-project.eu/data/fhir/StructureDefinition/MedicationRequest_Profile  | MedicationRequest_Profile |
https://emiga.rki.de/fhir/outbreak/StructureDefinition/OutbreakComposition  | OutbreakComposition |
https://www.ehealth.fgov.be/standards/fhir/problem/ValueSet/ProblemDiseaseCourseVS  | Condition Disease Course Value Set |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-caracteristicas-margen-quirurgico-VS  | Set de Valores de Caracteristicas del Margen Quirurgico |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-categorias-pTNM-VS  | Set de Valores para Categorias pTNM |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-estructuras-anatomincas-VS  | Set de Valores Para los Sitios del Cuerpo |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-invasion-linfatica-VS  | Set de Valores para Invasión Linfática y Vascular |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-metodos-medicion-VS  | Set de Valores de los Metodos de Medición del Tumor |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-morfologico-VS  | Set de Valores de Snomed CT para Anomalías Morfológica |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-observaciones-biopsia-VS  | Set de Valores para Observaciones Biopsia |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-procedimientos-biopsias-VS  | Set de Valores Para Procedimientos |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-reporte-biopsia-vs  | Set de Valores de los Reportes de Biopsia |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-respuestas-infiltracion-perineural-vs  | Set de Valores Para Hallazgos de Infiltración Perineural |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-respuestas-infiltracion-peritumoral-vs  | Set de Valores Para Hallazgos de Infiltración Peritumoral |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-snomed-hallazgos-clinicos-VS  | ValueSet de Snomed CT para Hallazgos Clínicos con Mapeo a CIE-10 |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-tipo-especimen-vs  | Set de Valores de los Tipos de Especimen |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-tipo-procedimientos-biopsias-VS  | Set de Valores Para Tipo de Procedimientos |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-tnm-categoria-metastasis-distante-patologico-vs  | Set de Valores Categoría TNM Patológico Metastásico Distante |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-tnm-categoria-nodo-regional-patologico-vs  | Set de Valores Categoría TNM Patológico Nodos Regional |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-tnm-categoria-tumor-primario-patologico-vs  | Set de Valores Categoría TNM Patológico Tumor Primario |
https://interoperabilidad.minsal.cl/fhir/ig/riap/ValueSet/riap-topografica-VS  | Set de Valores de Snomed CT para Topografía |
http://terminology.ehdsi.eu/ValueSet/eHDSIAnimalSpecies  | eHDSI Animal Species |
http://terminology.ehdsi.eu/ValueSet/eHDSIBloodGroup  | eHDSI Blood Group |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodySite  | eHDSI Body Site |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodySiteLaterality  | eHDSI Body Site Laterality |
http://terminology.ehdsi.eu/ValueSet/eHDSIBodyStructureLocation  | eHDSI Body Structure Location Qualifier |
http://terminology.ehdsi.eu/ValueSet/eHDSILabSpecimenType  | eHDSI Laboratory Specimen Type |
http://terminology.ehdsi.eu/ValueSet/eHDSILabTechnique  | eHDSI Laboratory Technique |
http://terminology.ehdsi.eu/ValueSet/eHDSIMedicalDevice  | eHDSI Medical Device |
http://terminology.ehdsi.eu/ValueSet/eHDSIMicroorganism  | eHDSI Microorganism |
http://terminology.ehdsi.eu/ValueSet/eHDSIMorphologicAbnormality  | eHDSI Morphologic Abnormality |
http://terminology.ehdsi.eu/ValueSet/eHDSIPresenceAbsence  | eHDSI Presence Absence |
http://terminology.ehdsi.eu/ValueSet/eHDSIReactionAllergy  | eHDSI Reaction Allergy |
https://ranzcr.com/fhir/ValueSet/radiology-referral  | RANZCR Radiology Referral |
http://terminology.ehdsi.eu/ValueSet/eHDSIAdverseEventType  | eHDSI Adverse Event Type |
http://terminology.ehdsi.eu/ValueSet/eHDSIAllergenNoDrug  | eHDSI Allergen No Drug |
http://terminology.ehdsi.eu/ValueSet/eHDSICodeProb  | eHDSI Code Prob |
http://terminology.ehdsi.eu/ValueSet/eHDSICurrentPregnancyStatus  | eHDSI Current Pregnancy Status |
http://terminology.ehdsi.eu/ValueSet/eHDSIOutcomeOfPregnancy  | eHDSI Outcome of Pregnancy |
http://terminology.ehdsi.eu/ValueSet/eHDSIProcedure  | eHDSI Procedure |
http://terminology.ehdsi.eu/ValueSet/eHDSIResolutionOutcome  | eHDSI Resolution Outcome |
http://terminology.ehdsi.eu/ValueSet/eHDSISeverity  | eHDSI Severity |
http://terminology.ehdsi.eu/ValueSet/eHDSISocialHistory  | eHDSI Social History |
http://terminology.ehdsi.eu/ValueSet/eHDSIStatusCode  | eHDSI Status Code |
http://terminology.ehdsi.eu/ValueSet/eHDSIVaccine  | eHDSI Vaccine |
http://hl7.org/fhir/us/pco/ValueSet/goal-barrier-codes  | Goal Barrier Assessment Codes |
http://hl7.org/fhir/us/pco/ValueSet/pco-goal-barrier-types-example-vs  | Goal Barrier Types Example |
http://hl7.org/fhir/us/pco/ValueSet/what-matters-codes-example  | What Matters Codes Example |
http://hl7.org/fhir/uv/lab-report/ValueSet/laterality-uv-lab  | Body Structure Laterality |
http://hl7.org/fhir/uv/lab-report/ValueSet/siteQualifier-uv-lab  | Body Structure Qualifier |
http://hl7.org/fhir/uv/lab-report/ValueSet/specialty-uv-lab  | Laboratory Specialty |
http://hl7.org/fhir/uv/lab-report/ValueSet/speciesType-uv-lab  | Types of species |
http://hl7.org/fhir/uv/lab-report/ValueSet/specimenAdditive-uv-lab  | Specimen Additive |
http://hl7.org/fhir/uv/lab-report/ValueSet/specimenContainer-uv-lab  | Specimen Container |
http://hl7.org/fhir/uv/lab-report/ValueSet/specimenType-uv-lab  | Specimen Types |
http://hl7.org/fhir/uv/lab-report/ValueSet/technique-uv-lab  | Laboratory Techniques |
http://hl7.org/cda/us/eyecare/ValueSet/AidToVisionCodes  | Aid to Vision Codes |
http://hl7.org/cda/us/eyecare/ValueSet/DiagnosticAssessmentEyeTestCodes  | Diagnostic Assessment Eye Test Value Set |
http://hl7.org/cda/us/eyecare/ValueSet/EyecareTargetSiteCodes  | Eyecare Target Site Codes |
http://hl7.org/cda/us/eyecare/ValueSet/PosteriorSegmentObservationCodes  | Posterior Segment Observation Codes |
http://hl7.org/cda/us/eyecare/ValueSet/PosteriorSegmentOrganizerCodes  | Posterior Segment Organizer Codes |
http://hl7.org/cda/us/eyecare/ValueSet/RefractionMethodCodes  | Refraction Method Codes |
http://hl7.org/cda/us/eyecare/ValueSet/RefractionObservationCodes  | Refraction Observation Codes |
http://hl7.org/cda/us/eyecare/ValueSet/VisualAcuityMethodCodes  | Visual Acuity Method Codes |
http://hl7.org/cda/us/eyecare/ValueSet/VisualAcuityObservationCodes  | Visual Acuity Observation Codes |
http://hl7.org/cda/us/eyecare/ValueSet/VisualAcuityOrganizerCodes  | Visual Acuity Organizer Codes |
https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-bodysite  | Body Site |
https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-laterality  | Laterality |
https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-reaction-manifestation-code  | Reaction Manifestation Code |
https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-score  | Score Value Set |
https://fhir.infoway-inforoute.ca/ValueSet/encountertype  | Encounter Type |
https://fhir.infoway-inforoute.ca/ValueSet/ethnicitycode  | EthnicityCode |
https://diab.iv.elga.gv.at/ValueSet/diagnose  | Diagnose |
https://diab.iv.elga.gv.at/ValueSet/fussdiagnose  | Fußdiagnose |
https://diab.iv.elga.gv.at/ValueSet/komplikationsdiagnose  | Komplikationsdiagnose |
https://diab.iv.elga.gv.at/ValueSet/nebendiagnose  | Nebendiagnose |
https://fhir.virtually.healthcare/ValueSet/BARSReferralCode  | BARS Referral Code |
https://fhir.virtually.healthcare/ValueSet/PatientReferral  | Patient Referral |
https://fhir.virtually.healthcare/ValueSet/SmokingStatus  | Smoking Status |
https://fhir.virtually.healthcare/ValueSet/VHConditionCode  | VH Condition Code |
https://fhir.virtually.healthcare/ValueSet/VHImmunisationCode  | VH Immunisation Code |
https://fhir.virtually.healthcare/ValueSet/VHMedicationCode  | VH Medication Code |
https://fhir.virtually.healthcare/ValueSet/VHObservationCode  | VH Observation Code |
https://fhir.virtually.healthcare/ValueSet/VHObservationValueCode  | VH Observation Value Code |
https://fhir.virtually.healthcare/ValueSet/document-entry-class  | DocumentEntry Class |
https://fhir.virtually.healthcare/ValueSet/document-entry-type  | DocumentEntry Type |
http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-contributing-factor-vs  | AdverseEvent Contributing Factor |
http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-mitigating-action-vs  | AdverseEvent Mitigating Action |
http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-supporting-info  | AdverseEvent Supporting Information |
http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-type-vs  | AdverseEvent Type |
https://www.ehealth.fgov.be/standards/fhir/medication/ValueSet/medication-exposure-category-vs  | Medication exposure intent |
http://hl7.org/fhir/uv/shc-vaccination/ValueSet/lab-result-findings  | Lab result findings (SNOMED CT) |
http://hl7.org/fhir/uv/shc-vaccination/ValueSet/specimen-collection-supervision-status  | Specimen Collection Supervision Status |
https://www.ehealth.fgov.be/standards/fhir/mycarenet/ValueSet/be-vs-basic-laterality  | Basic Laterality |
https://www.ehealth.fgov.be/standards/fhir/mycarenet/ValueSet/be-vs-toothnumber-bodysite  | Tooth Number Body Site |
https://profiles.ihe.net/ITI/Scheduling/ValueSet/sct-services  | IHE ITI Scheduling Snomed CT Services |
https://profiles.ihe.net/ITI/Scheduling/ValueSet/specialty  | IHE ITI Scheduling Specialties |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-certifier-types-vs  | Certifier Types Value Set |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-contributory-tobacco-use-vs  | Contributory Tobacco Use ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-death-certification-event-max-vs  | Event Code for Death Certificate Composition - Max |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-death-certification-event-vs  | Event Code for Death Certificate Composition |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-manner-of-death-vs  | Manner of Death ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-method-of-disposition-vs  | Method of Disposition ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-place-of-death-vs  | Place of Death ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-transportation-incident-role-vs  | Transportation Incident Role ValueSet |
https://hl7chile.cl/fhir/ig/clcore/ValueSet/VSDiagnosticosSCT  | Diagnósticos SNOMED y Ausente o Desconocido |
https://hl7.cz/fhir/lab/ValueSet/cz-lab-clinically-relevant-time-VS  | ValueSet - Clinically Relevant Time |
https://hl7.cz/fhir/lab/ValueSet/cz-lab-container-types-VS  | Laboratory Container Types (CZ) |
http://fhir.ch/ig/ch-orf/ValueSet/ch-orf-vs-consentstatus  | Consent Status |
http://fhir.ch/ig/ch-orf/ValueSet/ch-orf-vs-legalrelation  | Legal Relation |
http://fhir.ch/ig/ch-orf/ValueSet/ch-orf-vs-personalrelation  | Personal Relation |
http://ns.electronichealth.net.au/fhir/ValueSet/apgarscoretypesnomedct-1  | Apgar Score Type SNOMED CT |
http://ns.electronichealth.net.au/fhir/ValueSet/birthcomplication-1  | Birth Complication |
http://ns.electronichealth.net.au/fhir/ValueSet/birthmethod-1  | Birth Method |
http://ns.electronichealth.net.au/fhir/ValueSet/birthpresentation-1  | Birth Presentation |
http://ns.electronichealth.net.au/fhir/ValueSet/congenitalabnormality-1  | Congenital Abnormality |
http://ns.electronichealth.net.au/fhir/ValueSet/emergency-contact-type-1  | Emergency Contact Type |
http://ns.electronichealth.net.au/fhir/ValueSet/labourinductionmethod-1  | Labour Induction Method |
http://ns.electronichealth.net.au/fhir/ValueSet/labouronsettype-1  | Labour Onset Type |
https://nzhts.digital.health.nz/fhir/ValueSet/vaping-status  | Vaping Status |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-allergic-disposition-sct  | Allergic Disposition SCT |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-assessment-scales  | Assessment Scales |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-assessment  | Assessment |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-body-positioning-snomed  | Body Positioning SNOMED CT |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-drugs  | Drugs |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-observations  | Observations |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-procedures  | Procedures |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-radiologic-finding-sct  | Radiologic Finding SCT |
https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-substances-snomed  | Substances SNOMED CT |
http://fhir.ch/ig/ch-term/ValueSet/ActivePharmaceuticalIngredient  | ActivePharmaceuticalIngredient |
http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceConditionValueSet  | CH AllergyIntolerance Condition |
http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceReactionManifestationValueSet  | CH AllergyIntolerance Reaction Manifestation |
http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceReactionSubstanceValueSet  | CH AllergyIntolerance Reaction Substance |
http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceValueSet  | CH AllergyIntolerance |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.classCode  | DocumentEntry.classCode |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.confidentialityCode  | DocumentEntry.confidentialityCode |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.healthcareFacilityTypeCode  | DocumentEntry.healthcareFacilityTypeCode |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.practiceSettingCode  | DocumentEntry.practiceSettingCode |
http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.typeCode  | DocumentEntry.typeCode |
http://fhir.ch/ig/ch-term/ValueSet/HCProfessional.hcProfession  | HCProfessional.hcProfession |
http://fhir.ch/ig/ch-term/ValueSet/SubmissionSet.contentTypeCode  | SubmissionSet.contentTypeCode |
http://fhir.ch/ig/ch-term/ValueSet/UnitCode  | UnitCode |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-ch-vaccination-plan-immunizations-vs  | CH VACD Swiss Vaccination Plan Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-recommendation-categories-vs  | CH VACD Recommendation Categories for Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs  | CH VACD Target disease and illnesses undergone for immunization |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-vaccines-snomedct-vs  | CH VACD Snomed CT for VaccineCode |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-vaccines-vs  | CH VACD Swissmedic code for VaccineCode |
http://fhir.ch/ig/ch-term/ValueSet/snomedct-concept-viraldiseases-vs  | Snomed CT Concept Viral Diseases |
http://fhir.ch/ig/ch-term/ValueSet/treatmentreason  | Treatment Reason |
http://hl7.org/fhir/uv/cqm/ValueSet/chronic-liver-disease-legacy-example  | Chronic Liver Disease Legacy Example |
http://hl7.eu/fhir/base-r5/ValueSet/siteLaterality-eu  | Body Structure Laterality |
http://hl7.eu/fhir/base-r5/ValueSet/siteQualifier-eu  | Body Structure Qualifier |
http://hl7.eu/fhir/base-r5/ValueSet/speciesType-eu  | Types of species |
https://build.fhir.org/ig/ReMeDi-Blut/remedi_ig/ValueSet/blood-products-value-set  | BloodProductsValueSet |
http://fhir.ch/ig/ch-lab-order/ValueSet/MicrobiolProcedures  | Microbiological Procedure |
http://fhir.ch/ig/ch-lab-order/ValueSet/clinical-focus-vitamin-d  | Vitamin D all possible clinical contexts for test |
http://fhir.ch/ig/ch-lab-order/ValueSet/normal-contexts-vitamin-d  | Contexts for reimbursement of the vitamin D test |
http://fhir.ch/ig/ch-lab-order/ValueSet/reasons-for-order  | All Valid Reasons for Ordering a Lab Service |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-immunization-allergyintolerances-vs  | Allergies and Intolerance values for Immunization |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-medical-vs  | Swiss Medical Risks For Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-occupation-vs  | Swiss Occupation Risks For Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-preillness-vs  | Swiss Preillness Risks For Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-social-vs  | Swiss Social Risks For Immunizations |
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-verification-status-vs  | Verification Status Codes |
https://ncez.mzcr.cz/fhir/ValueSet/registering-provider-service-type-cz  | Registering Provider Service Type Cz |
http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-birth-attendant-titles-vr  | Value Set - Birth Attendants Titles Vital Records |
http://hl7.org/fhir/uv/livd/ValueSet/resultvalue-mappings-livd  | Result value mappings value set for LIVD |
https://fhir.hl7.at/elga/aps/r4/ValueSet/at-aps-immunization-vaccine-codes  | AT APS Immunitzation Vaccine Codes |
https://fhir.hl7.at/elga/aps/r4/ValueSet/at-aps-problems  | AT APS Problems |
http://bloodpressure.oemig.de/fhir/ValueSet/BodyPosition  | Body Position |
http://bloodpressure.oemig.de/fhir/ValueSet/MeasurementSetting  | Measurement Setting value set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-benign-uncertain-neoplasm-brain-cns-disorder-vs  | Benign Neoplasm of Brain and CNS Disorder Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-body-location-and-laterality-qualifier-vs  | Body Location and Laterality Qualifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-high-dose-rate-electronic-technique-vs  | Brachytherapy High Dose Rate Electronic Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-high-dose-rate-technique-vs  | Brachytherapy High Dose Rate Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-low-dose-rate-temporary-technique-vs  | Brachytherapy Low Dose Rate Temporary Radiation Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-modality-vs  | Brachytherapy Modality Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-permanent-seeds-technique-vs  | Brachytherapy Permanent Seeds Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-pulsed-dose-rate-technique-vs  | Brachytherapy Pulsed Dose Rate Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-brachytherapy-radiopharmaceutical-technique-vs  | Brachytherapy Radiopharmaceutical Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-breslow-depth-stage-value-vs  | Breslow Depth Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-body-location-vs  | Cancer Body Location Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-disease-status-evidence-type-vs  | Cancer Disease Status Evidence Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-related-surgical-procedure-vs  | Cancer-Related Surgical Procedure Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-stage-type-vs  | Cancer Stage Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-stage-value-vs  | Cancer Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-staging-method-vs  | Cancer Staging Method Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-staging-prognostic-factor-type-vs  | Cancer Staging Prognostic Factors Types |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-staging-prognostic-factor-value-vs  | Cancer Staging Prognostic Factors Value |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-carcinoma-in-situ-disorder-vs  | Carcinoma In-Situ Disorder Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-clark-level-value-vs  | Clark Level Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-clin-or-path-modifier-vs  | Clinical or Pathologic Modifier |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-condition-status-trend-max-vs  | Condition Status Trend Maximum Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-condition-status-trend-vs  | Condition Status Trend Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cytologic-evidence-malignancy-vs  | Cytologic Evidence of Malignancy Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-fab-classification-value-vs  | FAB Classification Value |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-figo-staging-method-vs  | FIGO Staging Method Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-gleason-grade-group-value-vs  | Gleason Grade Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-histologic-grade-vs  | Histologic Grade Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-histologic-grading-system-vs  | Histologic Grading System Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-histology-morphology-behavior-vs  | Histology Morphology Behavior Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-history-of-metastatic-malignant-neoplasm-vs  | History of Metastatic Malignant Neoplasm Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-hypereosinophilic-syndrome-disorder-vs  | Specific Diagnosis of Cancer Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-laterality-qualifier-vs  | Laterality Qualifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-stage-bulky-modifier-vs  | Lymphoma Stage Bulky Modifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-stage-value-modifier-vs  | Lymphoma Stage Value Modifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-stage-value-vs  | Lymphoma Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-staging-method-vs  | Lymphoma Staging System Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-melanoma-in-situ-disorder-vs  | Melanoma In-Situ Disorder Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-neuroblastoma-inss-value-vs  | International Neuroblastoma Staging System (INSS) for Neuroblastoma Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-normalization-basis-vs  | Normalization Basis Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-primary-malignant-neoplasm-disorder-vs  | Primary Malignant Neoplasm Disorder Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-procedure-intent-vs  | Procedure Intent Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-radiotherapy-treatment-location-qualifier-vs  | Radiotherapy Treatment Location Qualifier Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-radiotherapy-treatment-location-vs  | Radiotherapy Treatment Location Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-radiotherapy-volume-type-vs  | Radiotherapy Volume Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-rai-staging-method-vs  | Rai Staging System Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-rhabdomyosarcoma-assessment-value-vs  | Rhabdomyosarcoma Assessment Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-rhabdomyosarcoma-clinical-group-value-vs  | Rhabdomyosarcoma Clinical Group Value |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-risk-assessment-vs  | Risk Assessment Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-secondary-cancer-disorder-vs  | Secondary Cancer Disorder Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-teleradiotherapy-carbon-ion-beam-technique-vs  | Carbon Ion Beam Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-teleradiotherapy-electron-beam-technique-vs  | Electron Beam Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-teleradiotherapy-modality-vs  | Teleradiotherapy Modality Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-teleradiotherapy-neutron-beam-technique-vs  | Neutron Beam Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-teleradiotherapy-photon-beam-technique-vs  | Photon Beam Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-teleradiotherapy-proton-beam-technique-vs  | Proton Beam Technique Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-distant-metastases-category-vs  | TNM Distant Metastases Category Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-distant-metastases-staging-type-vs  | TNM Distant Metastases Staging Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-primary-tumor-category-vs  | TNM Primary Tumor Category Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-primary-tumor-staging-type-vs  | TNM Primary Tumor Staging Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-regional-nodes-category-vs  | TNM Regional Nodes Category Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-regional-nodes-staging-type-vs  | TNM Regional Nodes Staging Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-stage-group-staging-type-vs  | TNM Stage Group Staging Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-stage-group-vs  | TNM Stage Group Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-staging-method-vs  | TNM Staging Method Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-treatment-termination-reason-vs  | Treatment Termination Reason Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tumor-morphology-code-max-vs  | Tumor Morphology Code Max Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tumor-morphology-code-vs  | Tumor Morphology Code Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tumor-size-method-vs  | Tumor Size Method Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-wilms-tumor-body-site-vsCOG  | Wilms Tumor Body Site Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-wilms-tumor-stage-value-vs  | Wilms Tumor Stage Value Set |
http://terminology.hl7.org/uv/eyecare/ValueSet/body-site-eye  | Ophthalmic anatomical location |
http://terminology.hl7.org/uv/eyecare/ValueSet/conditions  | Ophthalmology Condition ICD10 and SNOMED codes ValueSet |
http://terminology.hl7.org/uv/eyecare/ValueSet/iop-methods  | Intraocular pressure (IOP) method v | https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Vehicle.Type.VS  | Paramedicine Vehicle Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Pathient.Transfer.to.Ambulance.Method.VS  | Pathient Transfer to Ambulance_Method Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Abdomen.TargetSite.VS  | Physical Finding of Abdomen Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Abdomen.VS  | Physical Finding of Abdomen Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Back.TargetSite.VS  | Physical Finding of Back Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Back.VS  | Physical Finding of Back Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Back.and.Spine.VS  | Physical Finding of Back and Spine Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Chest.TargetSite.VS  | Physical Finding of Chest Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Chest.VS  | Physical Finding of Chest Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Extremities.TargetSite.VS  | Physical Finding of Extremities Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Extremities.VS  | Physical Finding of Extremities Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Eye.TargetSite.VS  | Physical Finding of Eye Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Eye.VS  | Physical Finding of Eye Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Face.VS  | Physical Finding of Face Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.GenitourinaryTract.VS  | Physical Finding of Genitourinary Tract Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Head.VS  | Physical Finding of Head Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Heart.VS  | Physical Finding of Heart Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Lung.TargetSite.VS  | Physical Finding of Lung Tartget Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Lung.VS  | Physical Finding of Lung Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Neck.VS  | Physical Finding of Neck Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pelvis.VS  | Physical Finding of Pelvis Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pelvis.and.Genitourinary.VS  | Physical Finding of Pelvis and Genitourinary Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pupil.TargetSite.VS  | Physical Finding of Back and Spine Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pupil.VS  | Physical Finding of Pupil Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Skin.VS  | Physical Finding of Skin Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Spine.TargetSite.VS  | Physical Finding of Spine Spine Target Site Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Protective.Equipment.VS  | Protective Equipment Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Pulse.Rhythm.VS  | Pulse Rhythm Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Reason.For.Visit.VS  | Reason For Visit Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Respiratory.Effort.VS  | Respiratory Effort Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Response.VS  | Paramedicine Treatment Response Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Safety.Equipment.VS  | Safety Equipment Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Stroke.Assessment.Interpretation.VS  | Stroke Assessment Interpretation Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Stroke.Scale.Type.VS  | Stroke Scale Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Substance.Use.Evidence.VS  | Substance Use Evidence Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Transport.Method.VS  | Transport Method Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Vehicle.Type.VS  | Vehicle Type Value Set |
https://profiles.ihe.net/PCC/mPSC/ValueSet/Weight.Estimation.Tape.Values.VS  | Physical Finding of Pelvis and Genitourinary Value Set |
http://hl7.org/fhir/us/sdoh-clinicalcare/ValueSet/SDOHCC-ValueSetLOINCSNOMEDCT  | SDOHCC ValueSet LOINC SNOMEDCT |
http://hl7.org/fhir/uv/sdc/ValueSet/species  | Questionnaire Context Species |
http://hl7.org/fhir/uv/ips/ValueSet/allergies-intolerances-uv-ips  | Allergies & Intolerances - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/allergy-reaction-uv-ips  | Allergy Reaction - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/body-site-uv-ips  | Body Site - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/current-smoking-status-uv-ips  | Current Smoking Status - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/medical-devices-uv-ips  | Medical Devices - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/medication-example-uv-ips  | Medications - example (IPS) |
http://hl7.org/fhir/uv/ips/ValueSet/medication-uv-ips  | Medications - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/medicine-active-substances-uv-ips  | Medicine Active Substances - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/pregnancy-status-uv-ips  | Pregnancy Status - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/problems-uv-ips  | Problems - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/procedures-uv-ips  | Procedures - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-coded-values-laboratory-pathology-uv-ips  | Results Coded Values Laboratory/Pathology - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-numobs-uv-ips  | Results Radiology Measurement Observation - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-txtobs-uv-ips  | Results Radiology Textual Observation - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-specimen-collection-method-uv-ips  | Results Specimen Collection Method - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/results-specimen-type-uv-ips  | Results Specimen Type - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/target-diseases-uv-ips  | Vaccine Target Diseases - IPS |
http://hl7.org/fhir/uv/ips/ValueSet/vaccines-uv-ips  | Vaccines - IPS |
http://hl7.org/fhir/us/pacio-adi/ValueSet/ADIDocumentationTypeVS  | Documentation Types |
http://fhir.ch/ig/ch-epreg/ValueSet/blood-group  | CH EPREG VS: Blood Group |
http://fhir.ch/ig/ch-epreg/ValueSet/fetal-position  | CH EPREG VS: Fetal Position |
http://fhir.ch/ig/ch-epreg/ValueSet/parent  | CH EPREG VS: Parent |
http://hl7.org/fhir/uv/phenomics-exchange/ValueSet/Onset  | Onset ValueSet |
http://hl7.eu/fhir/imaging-r5/ValueSet/im-imaging-device-type  | Imaging Device Type |
http://hl7.eu/fhir/imaging-r5/ValueSet/im-procedure-type  | Imaging Procedure Type |
http://hl7.eu/fhir/imaging-r5/ValueSet/media-view  | Media View types - placeholder for cross-version extension |
http://hl7.eu/fhir/imaging-r5/ValueSet/periods-of-life-value-set  | Periods of Life |
http://fhir.health.gov.lk/ips/ValueSet/vs-follow-up-plan  | Follow-up plan |
http://fhir.health.gov.lk/ips/ValueSet/vs-medical-conditions  | Conditions |
http://fhir.health.gov.lk/ips/ValueSet/vs-reason-for-encounter  | Reason For Encounter |
http://fhir.health.gov.lk/ips/ValueSet/vs-risk-behaviour-physical-activity  | Physical Activity |
http://smart.who.int/ddcc/ValueSet/LabTestPathogenCovid19SnomedValueSet  | Lab Test - Pathogen - COVID-19 - SNOMED CT |
http://smart.who.int/ddcc/ValueSet/LabTestQualitativeResultSnomedValueSet  | Lab Test - Qualitative Result - SNOMED CT |
http://smart.who.int/ddcc/ValueSet/VaccineCovid19SnomedValueSet  | Vaccine - COVID-19 - SNOMED CT |
http://hl7.eu/fhir/laboratory/ValueSet/lab-laterality-eu-lab  | Body Structure Laterality |
http://hl7.eu/fhir/laboratory/ValueSet/lab-siteQualifier-eu-lab  | Body Structure Qualifier |
http://hl7.eu/fhir/laboratory/ValueSet/lab-specialty-eu-lab  | Laboratory Specialty |
http://hl7.eu/fhir/laboratory/ValueSet/lab-speciesType-eu-vs  | Types of species |
http://hl7.eu/fhir/laboratory/ValueSet/lab-specimenAdditive-eu-lab  | Specimen Additive |
http://hl7.eu/fhir/laboratory/ValueSet/lab-specimenContainer-eu-lab  | Specimen Container |
http://hl7.eu/fhir/laboratory/ValueSet/lab-specimenType-eu-lab  | Specimen Types |
http://hl7.eu/fhir/laboratory/ValueSet/lab-technique-eu-lab  | Laboratory Techniques |
http://hl7.org/fhir/us/central-cancer-registry-reporting/ValueSet/cancer-core-reportability-codes  | Cancer Core Reportability Codes |
https://hl7.fr/ig/fhir/medication/ValueSet/fr-treatment-intent  | French overall intention of the treatment |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-diabetes  | CVDRA Diabetes |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-percutaneous-coronary-intervention  | CVDRA Percutaneous Coronary Intervention |
https://nzhts.digital.health.nz/fhir/ValueSet/Smoking-status-code  | Smoking status |
https://nzhts.digital.health.nz/ns/ValueSet/health-service-type-refset-vs  | Health service type refset vs |
https://nzhts.digital.health.nz/fhir/ValueSet/air-status-reason-code  | AIR status reason code |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-coronary-artery-bypass-grafting  | CVDRA Coronary Artery Bypass Grafting |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-transient-ischaemic-attack  | CVDRA Transient Ischaemic Attack (TIA) |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-fh-premature-ischaemic-cvd  | CVDRA Family History Of Premature Ischaemic CVD |
https://nzhts.digital.health.nz/fhir/ValueSet/air-route-of-administration  | AIR route of administration |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-peripheral-vascular-disease  | CVDRA Peripheral Vascular Disease |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-renal-failure  | CVDRA Renal Failure |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-smoking-status  | CVDRA Smoking Status |
https://nzhts.digital.health.nz/ValueSet/cvdra-heart-failure  | CVDRA Heart failure |
https://nzhts.digital.health.nz/fhir/ValueSet/rheumatic-fever-care-team-participant-role  | Rheumatic fever care team participant role |
https://nzhts.digital.health.nz/fhir/ValueSet/cvdra-ischaemic-stroke  | CVDRA Ischaemic Stroke |
https://nzhts.digital.health.nz/fhir/ValueSet/air-disease-covered-code  | AIR diseases covered code |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-AJCC-residual-tumour  | NZ AJCC latest edition residual tumour category clinical |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-AJCC8-residual-tumour-clincal  | NZ AJCC 8th edition residual tumour category clinical |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-AJCC8-residual-tumour  | NZ AJCC (8th edition) edition residual tumour category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-acute-leukaemia-cancer-type  | NZ cancer acute leukaemia cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-adrenal-topography  | NZ cancer adrenal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ajcc-staging-chapter  | NZ AJCC staging chapter |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ajcc-staging-manual-edition  | NZ AJCC cancer staging manual edition |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ann-arbor-lymphoma-stage  | NZ cancer Ann Arbor lymphoma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-agressive-cancer-type  | NZ cancer aggressive B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-agressive-nhl-cancer-type  | NZ cancer aggressive non-Hodgkin B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-indolent-cancer-type  | NZ cancer indolent B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-indolent-nhl-cancer-type  | NZ cancer indolent non-Hodgkin B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-lymphoid-cancer-type  | NZ cancer B cell lymphoid cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-lymphoid-substream  | NZ cancer B cell lymphoid substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-lymphoma-cancer-type  | NZ cancer B cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-basis-of-cancer-diagnosis  | NZ cancer basis of diagnosis |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bl-ipi-prognostic-score  | NZ cancer BL-IPI prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-cancer-type  | NZ cancer bone cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-other-topography  | NZ cancer bone other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-pelvis-topography  | NZ cancer bone pelvis topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-thoracic-topography  | NZ cancer bone thoracic topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-bone-vertebral-column-topography  | NZ cancer bone vertebral column topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-ancillary-studies  | NZ cancer breast ancillary studies |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-clinical-behaviour-category  | NZ cancer breast clinical behaviour category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-clinical-presentation  | NZ cancer breast clinical presentation |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-mammogram-finding  | NZ cancer breast mammogram finding |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-non-nac-topography  | NZ cancer breast non-nipple-areola complex topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-procedure-image-guided-method  | NZ cancer breast procedure image guided method |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-radiology-type  | NZ cancer breast radiology type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-related-topography  | NZ cancer breast related topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-specimen-resection-procedure-type  | NZ cancer breast resection procedure type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-breast-ultrasound-finding  | NZ cancer breast ultrasound finding |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-colorectal-topography-resection  | NZ cancer gastrointestinal colorectal resection topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-colorectal-topography-subtype-metastectomy  | NZ cancer colorectal metastectomy topography subtype |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-laboratory-test-method  | NZ cancer laboratory test method |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-ngs-pcr  | NZ cancer PCR OR NGS test method |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-procedure-specimen-gi-cr-diagnostic  | NZ cancer gastrointestinal diagnostic specimen collection procedure |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-procedure-specimen-gi-cr-resection-met  | NZ cancer gastrointestinal colorectal metastecomy resection specimen collection procedure |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-procedure-specimen-gi  | NZ cancer gastrointestinal specimen collection procedure |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-service  | NZ cancer service |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-stream  | NZ cancer stream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cancer-topography-colonoscopy  | NZ cancer colonoscopy topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-clinical-impression-behaviour  | NZ cancer clinical impression of behaviour |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-clinical-scale  | NZ cancer clinical assessment scale |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-clockface-position  | NZ cancer clockface position |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-brain-topography  | NZ cancer central nervous system brain topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-cancer-type  | NZ cancer CNS cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-ipi-prognostic-score  | NZ cancer CNS-IPI for large B cell lymphoma prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-meninges-topography  | NZ cancer central nervous system meninges topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-nerve-topography  | NZ cancer central nervous system nerve topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-other-topography  | NZ cancer central nervous system other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-status-prognostic-score  | NZ cancer CNS status in acute lymphoblastic leukaemia lymphoma prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-cns-topography  | NZ cancer central nervous system topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-cancer-type  | NZ cancer colorectal cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-colon-perforation  | NZ perforation present in colon |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-obstruction-perforation  | NZ colorectal obstruction or perforation present in colon |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-obstruction  | NZ colorectal obstruction present |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-perforation  | NZ colorectal perforation present |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-colorectal-referral-criteria-surveillance  | NZ cancer colorectal surveillance colonoscopy referral criteria |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-data-absent-reason  | NZ cancer data absent reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-diagnosis-clinical-status  | NZ cancer diagnosis clinical status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-document-type  | NZ cancer document type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eln-prognostic-score  | NZ cancer ELN standardised reporting for genetic alteration in AML prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-neuroendocrine-cancer-type  | NZ cancer endocrine and neuroendocrine cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-neuroendocrine-substream  | NZ cancer endocrine and neuroendocrine substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-neuroendocrine-topography  | NZ cancer endocrine and/or neuroendocrine topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-other-topography  | NZ cancer endocrine other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-endocrine-topography  | NZ cancer endocrine topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-er-expression  | NZ cancer ER expression |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eutos-prognostic-score  | NZ cancer EUTOS for CML prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-excision-specimen-type  | NZ cancer excision specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-cancer-type  | NZ cancer eye and orbit cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-lacrimal-drainage-system-topography  | NZ cancer eye and orbit lacrimal drainage system topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-lacrimal-gland-topography  | NZ cancer eye and orbit lacrimal gland topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-optic-nerve-topography  | NZ cancer eye and orbit optic nerve topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-other-topography  | NZ cancer eye and orbit other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-eye-orbit-uveal-tract-topography  | NZ cancer eye and orbit uveal tract topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-cervix-uteri-topography  | NZ cancer female genital cervix uteri topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-corpus-uteri-topography  | NZ cancer female genital corpus uteri topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-fallopian-tube-topography  | NZ cancer female genital fallopian tube topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-gestational-trophoblastic-topography  | NZ cancer female genital gestational trophoblastic disease topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-peritoneum-topography  | NZ cancer female genital peritoneum topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-uterine-ligament-topography  | NZ cancer female genital uterine ligament topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-female-genital-vulva-topography  | NZ cancer female genital vulva topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2001-gestational-stage  | NZ cancer FIGO 2001 gestational trophoblastic disease stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2009-endometrial-carcinoma-stage  | NZ cancer FIGO 2009 endometrial carcinoma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2015-corpus-uteri-adenosarcoma-stage  | NZ cancer FIGO 2015 corpus uteri adenosarcoma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2018-cervix-uteri-stage  | NZ cancer FIGO 2018 cervix uteri stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-figo-2021-vulva-stage  | NZ cancer FIGO 2021 vulva stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-flipi-prognostic-score  | NZ cancer FLIPI prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-follicular-lymphoma-grade  | NZ cancer follicular lymphoma grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-frozen-section-specimen-type  | NZ cancer frozen section specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gastro-cancer-type  | NZ cancer gastrointestinal cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gastro-substream  | NZ cancer gastrointestinal substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-genitourinary-substream  | NZ cancer genitourinary substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-anus-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour anal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-appendix-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour appendix topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-colorectal-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour colorectal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-other-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-pancreas-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour pancreas topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-stomach-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour stomach topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-topography  | NZ cancer gastroenteropancreatic neuroendocrine tumour topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-german-hodgkin-stage  | NZ cancer GHSG Hodgkin treatment stratification stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-colon-topography  | NZ cancer gastrointestinal colon topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-colorectal-topography  | NZ cancer gastrointestinal colorectal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-duodenum-topography  | NZ cancer gastrointestinal duodenum topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-exocrine-pancreas-topography  | NZ cancer gastrointestinal exocrine pancreas topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-jejunum-ileum-topography  | NZ cancer gastrointestinal ileum and jejunum topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-liver-topography  | NZ cancer gastrointestinal liver topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-oesophagus-topography  | NZ cancer gastrointestinal oesophagus topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-pancreas-topography  | NZ cancer gastrointestinal pancreas topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-rectum-topography  | NZ cancer gastrointestinal rectum topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-stomach-topography  | NZ cancer gastrointestinal stomach topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-upper-topography  | NZ cancer upper gastrointestinal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-grade  | NZ cancer grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-grading-system  | NZ cancer grading system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haem-recurrence-type  | NZ cancer heamatology recurrence type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-stream  | NZ cancer haematology stream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-substream  | NZ cancer haematology substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-treatment-intent  | NZ cancer haematology treatment intent |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-cancer-type  | NZ cancer head and neck cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-hypopharynx-topography  | NZ cancer head and neck hypopharynx topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-larynx-topography  | NZ cancer head and neck larynx topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasal-paranasal-topography  | NZ cancer head and neck nasal cavity and paranasal sinus topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasal-topography  | NZ cancer head and neck nasal topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasopharynx-topography  | NZ cancer head and neck nasopharynx topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-odontogenic-topography  | NZ cancer head and neck odontogenic topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-other-topography  | NZ cancer head and neck other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-salivary-gland-topography  | NZ cancer head and neck major salivary gland topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-substream  | NZ cancer head and neck substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-with-thyroid-topography  | NZ cancer head and neck with thyroid topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-health-worker-role-path-radio-surg  | NZ cancer health worker role pathologist radiologist surgeon |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hep-pan-bil-other-topography  | NZ cancer other gastrointestinal hepatopancreaticobiliary topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hep-pan-bil-topography  | NZ cancer gastrointestinal hepatopancreaticobiliary topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-high-level-topography  | NZ cancer high level topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hl-ips-prognostic-score  | NZ cancer Hodgkin lymphoma International Prognostic Score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ipss-r-prognostic-score  | NZ cancer IPSS-R for MDS prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-mandatory  | NZ cancer laterality mandatory |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-optional  | NZ cancer laterality optional |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-or-side  | NZ cancer laterality or side |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-side-mandatory  | NZ cancer laterality or side mandatory |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-with-unknown  | NZ cancer laterality with unknown value |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality  | NZ cancer laterality |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lower-gastro-cancer-type  | NZ cancer lower gastrointestinal cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lugano-lymphoma-stage  | NZ cancer Lugano staging classification for lymphoma |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lung-cancer-type  | NZ lung cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymph-node-specimen-type  | NZ cancer lymph node specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-breast  | NZ cancer breast lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-eye-orbit  | NZ cancer eye and orbit lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-cervix-uteri  | NZ cancer female genital cervix uteri lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-corpus-uteri  | NZ cancer female genital corpus uteri lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-vulva  | NZ cancer female genital vulva lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-anus  | NZ cancer gastrointestinal anus lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-colorectal  | NZ cancer gastrointestinal colorectal lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-stomach  | NZ cancer gastrointestinal stomach lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal  | NZ cancer gastrointestinal lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-head-neck  | NZ cancer head and neck lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-male-genital  | NZ cancer male genital lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-thorax-lung  | NZ cancer thorax lung lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-thorax  | NZ cancer thorax lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-kidney  | NZ cancer urinary and male genital kidney lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-penis  | NZ cancer urinary and male genital penis lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-renal-pelvis-ureter  | NZ cancer urinary and male genital renal pelvis and ureter lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-renal-pelvis  | NZ cancer urinary and male genital renal pelvis lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-testis  | NZ cancer urinary and male genital testis lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-urinary-bladder  | NZ cancer urinary and male genital urinary bladder lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital  | NZ cancer urinary and male genital lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary  | NZ cancer urinary system lymph node |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphoma-substream  | NZ cancer lymphoma substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-male-genital-sact-cancer-type  | NZ cancer male genital SACT cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-male-genital-topography  | NZ cancer male genital topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-malt-ipi-prognostic-score  | NZ cancer MALT-IPI prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mastocytosis-cancer-type  | NZ cancer mastocytosis cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-md-anderson-residual-cancer-burden  | NZ cancer MD Anderson residual cancer burden |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mds-myeloproliferative-cancer-type  | NZ cancer myelodysplastic-myeloproliferative cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-melanoma-cancer-type  | NZ cancer melanoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-melanoma-cns-topography  | NZ cancer CNS melanoma topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-menopause-status  | NZ cancer menopause status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-midline-non-symmetrical-topography  | NZ cancer midline non-symmetrical topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-midline-topography  | NZ cancer midline topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mipi-prognostic-score  | NZ cancer MIPI prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mipss-70-v2-prognostic-score  | NZ cancer MIPSS 70+ v2.0 myelofibrosis prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-cns-cancer-type  | NZ cancer medical oncology cns cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-endocrine-cancer-type  | NZ cancer medical oncology endocrine cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-endocrine-neuroendocrine-cancer-type  | NZ medical oncology cancer endocrine and neuroendocrine cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-genitourinary-cancer-type  | NZ cancer medical oncology genitourinary cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-gynaecological-cancer-type  | NZ cancer medical oncology gynaecological cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-cancer-type  | NZ cancer medical oncology head and neck cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-other-cancer-type  | NZ cancer medical oncology other head and neck cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-other-topography  | NZ cancer medical oncology head and neck other topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-male-genital-topography  | NZ cancer medical oncology male genital topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-skin-melanoma-topography  | NZ cancer medical oncology skin and/or melanoma topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-skin-topography  | NZ cancer medical oncology skin topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-solid-tumour-cancer-type  | NZ cancer medical oncology solid tumour cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-solid-tumour-substream  | NZ cancer medical oncology solid tumour substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thoracic-cancer-type  | NZ cancer medical oncology thoracic cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thoracic-substream  | NZ cancer medicial oncology thoracic substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thorax-mesothelioma-topography  | NZ cancer thorax medical oncology mesothelioma topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thorax-topography  | NZ cancer thorax medical oncology topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-treatment-intent  | NZ cancer medical oncology treatment intent |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-urinary-male-genital-testicular-topography  | NZ cancer medical oncology urinary and male genital testicular topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-urinary-male-genital-topography  | NZ cancer medical oncology urinary and male genital topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-who-brain-primary-histology  | NZ medical oncology WHO brain primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-myeloid-cancer-type  | NZ cancer myeloid proliferation and myeloid neoplasm cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nail-topography  | NZ cancer nail topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nasal-paranasal-cancer-type  | NZ cancer nasal cavity and paranasal sinus cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-benign-reactive-diagnosis  | NZ cancer national cervical screening programme benign and reactive diagnosis |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-excision-completeness  | NZ cancer national cervical screening programme completeness of excision |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-specimen-type  | NZ cancer national cervical screening programme specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-topography  | NZ cancer national cervical screening programme topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neoadjuvant-therapy-response-system  | NZ cancer neoadjuvant therapy response system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neoadjuvant-therapy-type-non-hormone  | NZ cancer neoadjuvant therapy administration type (non-hormone) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-breast-topography  | NZ cancer neuroendocrine tumour breast topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-male-genital-topography  | NZ cancer neuroendocrine tumour male genital topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-urinary-topography  | NZ cancer neuroendocrine tumour urinary topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-gep-cancer-type  | NZ cancer neuroendocrine GEP cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-non-gep-cancer-type  | NZ cancer neuroendocrine non GEP cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-substream  | NZ cancer neuroendocrine substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-ajcc-staging-system  | NZ cancer non-AJCC staging system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-hodgkin-lymphoma-cancer-type  | NZ cancer non Hodgkin lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-prostate-genitourinary-cancer-type  | NZ cancer genitourinary (non prostate) cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-not-performed-reason  | NZ cancer not performed reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nottingham-grade  | NZ Nottingham Combined grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nuclear-grade  | NZ cancer nuclear grade of DCIS grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-observation  | NZ cancer observation code |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-parathryoid-topography  | NZ cancer parathryoid topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-percist-1-cancer-burden  | NZ cancer PERCIST 1.0 cancer burden |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-performance-status  | NZ cancer performance status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pharynx-larynx-cancer-type  | NZ cancer pharynx and larynx and trachea cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pit-prognostic-score  | NZ cancer PIT prognostic score |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pituitary-net-topography  | NZ cancer pituitary neuroendocrine tumour topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-polyp-morphology-specimen-type  | NZ cancer polyp morphology specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pos-neg-result  | NZ cancer positive negative result |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-presence-tumour-finding  | NZ cancer presence of tumour finding |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-procedure-status  | NZ cancer procedure status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-prognostic-scoring-system  | NZ cancer prognostic scoring system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-radiology-type  | NZ cancer radiology type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-rai-cll-stage  | NZ cancer Rai staging for CLL stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-recist-1-1-cancer-burden  | NZ cancer RECIST 1.1 cancer burden |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-recurrence-type  | NZ cancer recurrence type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-referral-criteria-procedure-assessment  | NZ cancer procedure referral criteria assessment |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-revised-mayo-amyloidosis-stage  | NZ cancer revised Mayo staging 2012 for AL (amyloidosis) stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-revised-multiple-myeloma-stage  | NZ cancer R-ISS for multiple myeloma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ro-beam-energy-type  | NZ cancer radiation oncology beam energy type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ro-planning-technique  | NZ cancer radiation oncology planning technique |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-aml-disease-response  | NZ SACT acute myeloid leukemia disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-amyloidosis-disease-response  | NZ SACT amyloidosis disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cancer-substream  | NZ systemtic anti-cancer therapy substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cancer-type  | NZ SACT cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cll-sll-disease-response  | NZ SACT chronic lymphocytic leukemia and small lymphocytic lymphoma disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cml-disease-response  | NZ SACT chronic myeloid leukemia disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-dose-form  | NZ SACT dose form |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-dose-unit  | NZ SACT dose unit |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-ecog-status  | NZ SACT ECOG status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-haem-disease-response  | NZ SACT haematology disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-heam-disease-response  | NZ SACT heamatology disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-mds-disease-response  | NZ SACT myelodysplastic syndrome disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-mo-disease-response  | NZ SACT medical oncology disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-non-small-lymphocytic-disease-response  | NZ SACT lymphoma (non small lymphocytic) disease response |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-overall-discontinue-reason  | NZ SACT overall discontinue reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-patient-factor-discontinue-reason  | NZ SACT patient factor discontinue |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-pr-expression  | NZ SACT PR expression |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-toxicity-discontinue-reason  | NZ systemic anti-cancer therapy toxicity discontinue reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-side-mandatory  | NZ cancer side mandatory |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-side  | NZ cancer side |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-simple-performance-status  | NZ cancer simple performance status |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-cancer-type  | NZ cancer skin cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-extremity-topography  | NZ cancer skin of extremity topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-head-neck-topography  | NZ cancer skin of head and neck topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-melanoma-substream  | NZ cancer skin and melanoma substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-topography  | NZ cancer skin topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-trunk-topography  | NZ cancer skin of trunk topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-abdomen-pelvis-topography  | NZ cancer soft tissue abdomen and pelvis topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-bone-cancer-type  | NZ cancer soft tissue and bone cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-bone-substream  | NZ cancer soft tissue and bone substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-extremity-topography  | NZ cancer soft tissue extremity topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-head-neck-topography  | NZ cancer soft tissue head and neck topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-skin-topography  | NZ cancer soft tissue skin topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-thoracic-topography  | NZ cancer soft tissue thoracic topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-non-ajcc-staging-system  | NZ cancer solid tumour non-AJCC staging system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-sact-cancer-type  | NZ cancer solid tumour SACT cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-staging-system  | NZ cancer solid tumour staging system |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-substream  | NZ cancer solid tumour substream |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-category-excision-biopsy  | NZ cancer specimen category biopsy or excision |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-category  | NZ cancer specimen category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-colorectal-screening-colonoscopy-type  | NZ cancer colorectal screening colonoscopy specimen type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-dimension-type  | NZ cancer specimen dimension type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-polyp-profile  | NZ cancer polyp profile type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-stage-classification  | NZ cancer stage classification |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-intent  | NZ surgical intent |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-margin-proximal-distal  | NZ cancer surgical margin qualifier proximal or distal |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-margin-type  | NZ cancer surgical margin type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-t-nk-cell-lymphoma-cancer-type  | NZ cancer T/NK cell lymphoma cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-test-failure-reason  | NZ cancer test failure reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-test-inconclusive-reason  | NZ cancer test inconclusive reason |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thoracic-cancer-type  | NZ cancer thoracic cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-lung-lobe-topography  | NZ cancer thorax lung lobe topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-soft-tissue-topography  | NZ cancer thorax soft tissue topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-thymus-topography  | NZ cancer thorax thymus topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-topography  | NZ cancer thorax topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thryoid-topography  | NZ cancer thryoid topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thyroid-topography  | NZ cancer thyroid topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-b-lymphoma-stage  | NZ cancer revised TNM-B staging for cutaneous T cell lymphoma stage |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-clinical-stage-group  | NZ AJCC breast clinical stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-cm  | NZ AJCC breast clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-ct  | NZ AJCC breast clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pathological-stage-group  | NZ AJCC breast pathological stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pn  | NZ AJCC breast pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pt  | NZ AJCC breast pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-stage-group  | NZ AJCC breast stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-clinical-stage-group  | NZ AJCC clinical stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-cm  | NZ AJCC clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-gen-corpus-uteri-leiomyosarcoma-stage-group  | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-cm  | NZ AJCC female genital cervix uteri clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-ct  | NZ AJCC female genital cervix uteri clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-pm  | NZ AJCC female genital cervix uteri pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-pt  | NZ AJCC female genital cervix uteri pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-stage-group  | NZ AJCC female genital cervix uteri stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-cn  | NZ AJCC female genital corpus uteri adenosarcoma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-pt  | NZ AJCC female genital corpus uteri adenosarcoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-cn  | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-ct  | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-pt  | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-stage-group  | NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-cm  | NZ AJCC female genital corpus uteri clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-cn  | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-ct  | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-pt  | NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pm  | NZ AJCC female genital corpus uteri pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pn  | NZ AJCC female genital corpus uteri pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pt  | NZ AJCC female genital corpus uteri pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-stage-group  | NZ AJCC female genital corpus uteri stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ct  | NZ AJCC female genital clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-gestational-pm  | NZ AJCC female genital gestational trophoblastic disease pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-gestational-stage-group  | NZ AJCC female genital gestational trophoblastic disease stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-cm  | NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-pt  | NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-pm  | NZ AJCC female genital pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-cn  | NZ AJCC female genital vagina clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pm  | NZ AJCC female genital vagina pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pn  | NZ AJCC female genital vagina pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pt  | NZ AJCC female genital vagina pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-stage-group  | NZ AJCC female genital vagina stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-ct  | NZ AJCC female genital vulva clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pm  | NZ AJCC female genital vulva pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pn  | NZ AJCC female genital vulva pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pt  | NZ AJCC female genital vulva pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-clinical-stage-group  | NZ AJCC gastrointestinal clinical stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-cn  | NZ AJCC gastrointestinal clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-cm  | NZ AJCC gastrointestinal colon and rectum clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-cn  | NZ AJCC gastrointestinal colon and rectum clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-ct  | NZ AJCC gastrointestinal colon and rectum clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-pn  | NZ AJCC gastrointestinal colon and rectum pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-stage-group  | NZ AJCC gastrointestinal colon and rectum stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-pn  | NZ AJCC gastrointestinal pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-yp-stage-group  | NZ AJCC gastrointestinal pathological post therapy (neoadjuvant) stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-cm  | NZ AJCC gastrointestinal stromal tumour clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-cn  | NZ AJCC gastrointestinal stromal tumour clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-ct  | NZ AJCC gastrointestinal stromal tumour clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-other-stage-group  | NZ AJCC gastrointestinal stromal tumour small intestine and oesophageal and colon and rectum and mesenteric and peritoneal stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-pm  | NZ AJCC gastrointestinal stromal tumour pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-pn  | NZ AJCC gastrointestinal stromal tumour pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-cll-or-sll-stage-group  | NZ AJCC haematology chronic lymphocytic leukemia or small lymphocytic lymphoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-cn  | NZ AJCC haematology clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-hl-or-nhl-stage-group  | NZ AJCC haematology Hodgkin or non-Hodgkin lymphoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-cm  | NZ AJCC haematology mycosis fungoides or sezary syndrome clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-cn  | NZ AJCC haematology mycosis fungoides or sezary syndrome clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-ct  | NZ AJCC haematology mycosis fungoides or sezary syndrome clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-pm  | NZ AJCC haematology mycosis fungoides or sezary syndrome pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-pn  | NZ AJCC haematology mycosis fungoides or sezary syndrome pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-pt  | NZ AJCC haematology mycosis fungoides or sezary syndrome pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-non-mf-or-ss-cm  | NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-non-mf-or-ss-ct  | NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-non-mf-or-ss-pm  | NZ AJCC haematology cutaneous B cell or T cell non Mycosis fungoides and non-sezary syndrome lymphoma pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-paed-hl-stage-group  | NZ AJCC haematology pediatric Hodgkin lymphoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-pn  | NZ AJCC haematology pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-pt  | NZ AJCC haematology pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-cm  | NZ AJCC neuroendocrine gastrointestinal colon and rectum clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-pt  | NZ AJCC neuroendocrine gastrointestinal colon and rectum pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-stage-group  | NZ AJCC neuroendocrine gastrointestinal colon and rectum stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-ct  | NZ AJCC neuroendocrine gastrointestinal clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-pm  | NZ AJCC neuroendocrine gastrointestinal pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-pn  | NZ AJCC neuroendocrine gastrointestinal pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-stage-group  | NZ AJCC neuroendocrine gastrointestinal stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-pathological-stage-group  | NZ AJCC pathological stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-pm  | NZ AJCC pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-pt  | NZ AJCC pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-rcn  | NZ AJCC recurrence or retreatment clinical N category (rcN) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-rpn  | NZ AJCC recurrence or retreatment pathological N category (rpN) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-stage-classification  | NZ TNM stage classification |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-stage-clinical-classification  | NZ clinical TNM stage classification |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-suffix  | NZ TNM suffix |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-cn  | NZ AJCC thoracic clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-ct  | NZ AJCC thoracic clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-lung-cm  | NZ AJCC thoracic lung clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-lung-cn  | NZ AJCC thoracic lung clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-lung-stage-group  | NZ AJCC thoracic lung stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-cn  | NZ AJCC thoracic malignant pleural mesothelioma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-pm  | NZ AJCC thoracic malignant pleural mesothelioma pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-pn  | NZ AJCC thoracic malignant pleural mesothelioma pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-pt  | NZ AJCC thoracic malignant pleural mesothelioma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-stage-group  | NZ AJCC thoracic malignant pleural mesothelioma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pn  | NZ AJCC thoracic pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-stage-group  | NZ AJCC thoracic stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-cm  | NZ AJCC thoracic thymus clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-cn  | NZ AJCC thoracic thymus clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-ct  | NZ AJCC thoracic thymus clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-pt  | NZ AJCC thoracic thymus pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-stage-group  | NZ AJCC thoracic thymus stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-ypn  | NZ AJCC post therapy (neoadjuvant) pathological N category (ypN) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-clinical-stage-group  | NZ AJCC (8th edition) breast clinical stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-cn  | NZ AJCC (8th edition) breast clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-ct  | NZ AJCC (8th edition) breast clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-pn  | NZ AJCC (8th edition) breast pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-pt  | NZ AJCC (8th edition) breast pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-gen-ovary-fallopian-peritoneal-stage-group  | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cervix-uteri-cm  | NZ AJCC (8th edition) female genital cervix uteri clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cervix-uteri-pt  | NZ AJCC (8th edition) female genital cervix uteri pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cervix-uteri-stage-group  | NZ AJCC (8th edition) female genital cervix uteri stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cn  | NZ AJCC (8th edition) female genital clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-adenosarcoma-ct  | NZ AJCC (8th edition) female genital corpus uteri adenosarcoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-adenosarcoma-pt  | NZ AJCC (8th edition) female genital corpus uteri adenosarcoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-carcinoma-ct  | NZ AJCC (8th edition) female genital corpus uteri carcinoma and carcinosarcoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-carcinoma-stage-group  | NZ AJCC (8th edition) female genital corpus uteri carcinoma and carcinosarcoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-cn  | NZ AJCC (8th edition) female genital corpus uteri clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-cn  | NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-ct  | NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-pt  | NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-pn  | NZ AJCC (8th edition) female genital corpus uteri pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-pt  | NZ AJCC (8th edition) female genital corpus uteri pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-stage-group  | NZ AJCC (8th edition) female genital corpus uteri stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ct  | NZ AJCC (8th edition) female genital clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-gestational-pm  | NZ AJCC (8th edition) female genital gestational trophoblastic disease pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-gestational-stage-group  | NZ AJCC (8th edition) female genital gestational trophoblastic disease stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-cm  | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-ct  | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-pm  | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-pn  | NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-pm  | NZ AJCC (8th edition) female genital pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-pt  | NZ AJCC (8th edition) female genital pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-stage-group  | NZ AJCC (8th edition) female genital stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vagina-pm  | NZ AJCC (8th edition) female genital vagina pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vagina-pt  | NZ AJCC (8th edition) female genital vagina pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vagina-stage-group  | NZ AJCC (8th edition) female genital vagina stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-cm  | NZ AJCC (8th edition) female genital vulva clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-cn  | NZ AJCC (8th edition) female genital vulva clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-pm  | NZ AJCC (8th edition) female genital vulva pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-pn  | NZ AJCC (8th edition) female genital vulva pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-pt  | NZ AJCC (8th edition) female genital vulva pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-stage-group  | NZ AJCC (8th edition) female genital vulva stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-clinical-stage-group  | NZ AJCC (8th edition) gastrointestinal clinical stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-cn  | NZ AJCC (8th edition) gastrointestinal colon and rectum clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-ct  | NZ AJCC (8th edition) gastrointestinal colon and rectum clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-pm  | NZ AJCC (8th edition) gastrointestinal colon and rectum pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-pn  | NZ AJCC (8th edition) gastrointestinal colon and rectum pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-pt  | NZ AJCC (8th edition) gastrointestinal colon and rectum pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-stage-group  | NZ AJCC (8th edition) gastrointestinal colon and rectum stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-pathological-stage-group  | NZ AJCC (8th edition) gastrointestinal pathological stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-pn  | NZ AJCC (8th edition) gastrointestinal pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-pt  | NZ AJCC (8th edition) gastrointestinal pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-yp-stage-group  | NZ AJCC (8th edition) gastrointestinal pathological post therapy (neoadjuvant) stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-cn  | NZ AJCC (8th edition) gastrointestinal stromal tumour clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-ct  | NZ AJCC (8th edition) gastrointestinal stromal tumour clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-pm  | NZ AJCC (8th edition) gastrointestinal stromal tumour pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-pn  | NZ AJCC (8th edition) gastrointestinal stromal tumour pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-pt  | NZ AJCC (8th edition) gastrointestinal stromal tumour pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-cm  | NZ AJCC (8th edition) haematology clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-cn  | NZ AJCC (8th edition) haematology clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-ct  | NZ AJCC (8th edition) haematology clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-hl-or-nhl-stage-group  | NZ AJCC (8th edition) haematology Hodgkin or non Hodgkin lymphoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-cm  | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-cn  | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-ct  | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-pm  | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-pn  | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-pt  | NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-cm  | NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-ct  | NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-pm  | NZ AJCC (8th edition) haematology cutaneous B cell or T cell non mycosis fungoides and non sezary syndrome lymphoma pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-pt  | NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-paed-hl-stage-group  | NZ AJCC (8th edition) haematology pediatric Hodgkin lymphoma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-pcm-stage-group  | NZ AJCC (8th edition) haematology plasma cell myeloma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-pn  | NZ AJCC (8th edition) haematology pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-stage-group  | NZ AJCC (8th edition) haematology stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-cn  | NZ AJCC (8th edition) neuroendocrine gastrointestinal clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-cm  | NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-cn  | NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-pm  | NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-pt  | NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-pm  | NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-pn  | NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-pt  | NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-stage-group  | NZ AJCC (8th edition) neuroendocrine gastrointestinal stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-cm  | NZ AJCC (8th edition) thoracic clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-ct  | NZ AJCC (8th edition) thoracic lung clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-pn  | NZ AJCC (8th edition) thoracic lung pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-pt  | NZ AJCC (8th edition) thoracic lung pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-stage-group  | NZ AJCC (8th edition) thoracic lung stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pleural-cn  | NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pleural-ct  | NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pleural-pm  | NZ AJCC (8th edition) thoracic malignant pleural mesothelioma pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pleural-stage-group  | NZ AJCC (8th edition) thoracic malignant pleural mesothelioma stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pn  | NZ AJCC (8th edition) thoracic pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-pt  | NZ AJCC (8th edition) thoracic pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-thymus-cm  | NZ AJCC (8th edition) thoracic thymus clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-thymus-cn  | NZ AJCC (8th edition) thoracic thymus clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-thymus-pm  | NZ AJCC (8th edition) thoracic thymus pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-thymus-stage-group  | NZ AJCC (8th edition) thoracic thymus stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-cm  | NZ AJCC (9th edition) female genital cervix uteri clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-cn  | NZ AJCC (9th edition) female genital cervix uteri clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-ct  | NZ AJCC (9th edition) female genital cervix uteri clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-pt  | NZ AJCC (9th edition) female genital cervix uteri pathological T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cervix-uteri-stage-group  | NZ AJCC (9th edition) female genital cervix uteri stage group |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cm  | NZ AJCC (9th edition) female genital clinical M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-cn  | NZ AJCC (9th edition) female genital clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-ct  | NZ AJCC (9th edition) female genital clinical T category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-pm  | NZ AJCC (9th edition) female genital pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-pn  | NZ AJCC (9th edition) female genital pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-vulva-cn  | NZ AJCC (9th edition) female genital vulva clinical N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-vulva-pm  | NZ AJCC (9th edition) female genital vulva pathological M category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm9-female-genital-vulva-pn  | NZ AJCC (9th edition) female genital vulva pathological N category |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-treatment-intent  | NZ cancer treatment intent |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tumour-focality  | NZ cancer tumour focality |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tumour-origin  | NZ cancer tumour origin |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-unknown-site-topography  | NZ cancer unknown site topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-upper-gastro-cancer-type  | NZ cancer upper gastrointestinal cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-kidney-topography  | NZ cancer urinary and male genital kidney topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-prostate-topography  | NZ cancer urinary and male genital prostate topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-renal-pelvis-ureter-topography  | NZ cancer urinary and male genital renal pelvis and ureter topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-testicular-adnexa-topography  | NZ cancer urinary and male genital testicular adnexa topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-testicular-topography  | NZ cancer urinary and male genital testicular topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-testis-topography  | NZ cancer urinary and male genital testis topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-male-genital-urinary-bladder-topography  | NZ cancer urinary and male genital urinary bladder topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-system-cancer-type  | NZ cancer urinary system cancer type |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-urinary-topography  | NZ cancer urinary system topography |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-aggressive-nh-bcell-lymphoma-histology  | NZ WHO haematolymphoid aggressive non-hodgkin B cell lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-anus-primary-histology  | NZ WHO anus primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-appendix-site-histology  | NZ WHO appendix site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-bladder-primary-histology  | NZ WHO urinary bladder primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-bone-haematolymphoid-histology  | NZ WHO bone haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-bone-histology  | NZ WHO bone histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-brain-primary-histology  | NZ WHO brain primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-brain-site-histology  | NZ WHO brain site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-haematolymphoid-histology  | NZ WHO breast haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-in-situ-carcinoma-histology  | NZ WHO breast ductal carcinoma in situ histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-invasive-carcinoma-histology  | NZ WHO breast invasive carcinoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-invasive-histology  | NZ WHO breast invasive histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-nipple-histology  | NZ WHO breast tumour of nipple histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-primary-histology  | NZ WHO breast primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-uncertain-borderline-histology  | NZ WHO breast uncertain and borderline histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-cranial-paraspinal-nerve-histology  | NZ WHO central nervous system cranial and paraspinal nerve histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-grade  | NZ WHO central nervous system tumour grade reference set |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-haematolymphoid-histology  | NZ WHO central nervous system haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-melanocytic-histology  | NZ WHO central nervous system melanocytic histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-meningioma-histology  | NZ WHO central nervous system meningioma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-pineal-histology  | NZ WHO central nervous system pineal histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-cns-sellar-region-histology  | NZ WHO central nervous system sellar region histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-colorectal-primary-histology  | NZ WHO colorectal primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-colorectal-site-histology  | NZ WHO colorectal site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-conjunctiva-primary-histology  | NZ WHO conjunctiva primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-differentiation-excl-undifferentiated-grade  | NZ WHO malignant differentiation excluding undifferentiated grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-differentiation-grade  | NZ WHO malignant differentiation grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-appendix-histology  | NZ WHO digestive system appendix histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-colon-rectum-histology  | NZ WHO digestive system colon and rectum histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-malignant-histology  | NZ WHO digestive system malignant tumour histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-mesenchymal-histology  | NZ WHO digestive system mesenchymal histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-oesophagus-histology  | NZ WHO digestive system oesophagus histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-digestive-uncertain-histology  | NZ WHO digestive system uncertain behaviour tumour histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-cortex-histology  | NZ WHO endocrine and neuroendocrine adrenal gland histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-cortex-primary-histology  | NZ WHO endocrine and neuroendocrine adrenal cortex primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-cortex-site-histology  | NZ WHO endocrine and neuroendocrine adrenal cortex site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-medulla-primary-histology  | NZ WHO endocrine and neuroendocrine adrenal medulla primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-primary-histology  | NZ WHO endocrine and neuroendocrine adrenal gland including adrenal medulla primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-site-histology  | NZ WHO endocrine and neuroendocrine adrenal gland including adrenal medulla site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-germ-cell-histology  | NZ WHO endocrine and neuroendocrine germ cell histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-malignant-histology  | NZ WHO endocrine and neuroendocrine malignant histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-paraganglioma-primary-histology  | NZ WHO endocrine and neuroendocrine paraganglioma primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-parathyroid-primary-histology  | NZ WHO endocrine and neuroendocrine parathyroid gland primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-parathyroid-site-histology  | NZ WHO endocrine and neuroendocrine parathyroid gland site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-pituitary-histology  | NZ WHO endocrine and neuroendocrine pituitary gland histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-primary-pituitary-histology  | NZ WHO endocrine and neuroendocrine pituitary gland primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-primary-pituitary-net-histology  | NZ WHO pituitary neuroendocrine tumour primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-thyroid-histology  | NZ WHO endocrine and neuroendocrine thyroid gland histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-thyroid-primary-histology  | NZ WHO endocrine and neuroendocrine thyroid gland primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-uncertain-histology  | NZ WHO endocrine and neuroendocrine uncertain behaviour histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-primary-histology  | NZ WHO endocrine primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-behaviour-free-histology  | NZ WHO eye and orbit behaviour free histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-eyelid-histology  | NZ WHO eye and orbit eyelid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-haematolymphoid-histology  | NZ WHO eye and orbit haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-in-situ-histology  | NZ WHO eye and orbit in situ histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-lacrimal-gland-histology  | NZ WHO eye and orbit lacrimal gland histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-optic-disc-nerve-histology  | NZ WHO eye and orbit optic disc and optic nerve histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eye-orbit-uveal-tract-histology  | NZ WHO eye and orbit uveal tract histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-eyelid-site-histology  | NZ WHO eyelid site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-fallopian-tube-primary-histology  | NZ WHO fallopian tube primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-breast-primary-minus-nipple-histology  | NZ WHO female breast primary (no nipple) histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-gestational-trophoblastic-histology  | NZ WHO female genital gestational trophoblastic disease histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-haematolymphoid-histology  | NZ WHO female genital haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-histology  | NZ WHO female genital histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-melanocytic-histology  | NZ WHO female genital melanocytic lesion histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-mesenchymal-histology  | NZ WHO female genital mesenchymal tumour of lower genital tract histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-neuroendocrine-histology  | NZ WHO female genital neuroendocrine histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-ovary-histology  | NZ WHO female genital ovary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-peritoneum-histology  | NZ WHO female genital peritoneum histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-uterine-ligament-histology  | NZ WHO female genital uterine ligament histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-vagina-histology  | NZ WHO female genital vagina histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-female-genital-vulva-histology  | NZ WHO female genital vulva histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-gep-net-primary-histology  | NZ WHO neuroendocrine tumour gastroenteropancreatic (GEP-NET) primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-gestational-trophoblastic-site-histology  | NZ WHO gestational trophoblastic site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-all-bcell-histology  | NZ WHO haematolymphoid B lymphoblastic leukaemia lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-all-histology  | NZ WHO haematolymphoid acute lymphoblastic leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-all-tcell-histology  | NZ WHO haematolymphoid T lymphoblastic leukemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-b-cell-histology  | NZ WHO hematolymphoid B cell lymphoid proliferation or lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-b-cell-lymphoid-histology  | NZ WHO haematolymphoid B cell lymphoid neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-b-cell-lymphoma-histology  | NZ WHO haematolymphoid B cell lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-bl-histology  | NZ WHO haematolymphoid Burkitt lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-castleman-disorder-histology  | NZ WHO haematolymphoid Castleman disease histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-chronic-leukaemia-histology  | NZ WHO haematolymphoid chronic leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-cmml-histology  | NZ WHO haematolymphoid chronic myelomonocytic leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-cnl-histology  | NZ WHO haematolymphoid chronic neutrophilic leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-cutaneous-t-cell-lymphoma-histology  | NZ WHO haematolymphoid primary cutaneous T cell lymphoproliferative disorder histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-et-histology  | NZ WHO haematolymphoid essential thrombocythaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-extranod-nk-t-cell-lymphoid-histology  | NZ WHO haematolymphoid extranodal NK/T cell lymphoid proliferation histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-extranod-nk-t-cell-lymphoma-histology  | NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-hcl-histology  | NZ WHO haematolymphoid hairy cell leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-histiocytic-histology  | NZ WHO hematolymphoid histiocytic dendritic cell neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-histiocytic-other-histology  | NZ WHO haematolymphoid histiocytic dendritic cell neoplasm other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-intestinal-nk-t-cell-lymphoid-histology  | NZ WHO classification of tumours haematolymphoid intestinal T-cell and natural killer cell lymphoid proliferation histology reference set |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-leukaemia-histology  | NZ WHO haematolymphoid leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-lymphoma-not-sll-histology  | NZ WHO haematolymphoid lymphoma excluding small lymphocytic disease histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-lymphoplasmacytic-lymphoma-histology  | NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mast-cell-sarcoma-histology  | NZ WHO haematolymphoid mast cell sarcoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mastocytosis-other-histology  | NZ WHO haematolymphoid mastocytosis other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mc-lymphoma-histology  | NZ WHO haematolymphoid mantle cell lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mds-histology  | NZ WHO haematolymphoid myelodysplastic syndrome histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mds-myeloproliferative-histology  | NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mds-myeloproliferative-other-histology  | NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mpn-other-histology  | NZ WHO haematolymphoid myeloproliferative neoplasm other leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloid-histology  | NZ WHO hematolymphoid myeloid proliferation or neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloid-other-histology  | NZ WHO haematolymphoid myeloid proliferation or neoplasm other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloid-secondary-histology  | NZ WHO classification of tumours haematolymphoid secondary myeloid neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloma-histology  | NZ WHO haematolymphoid myeloma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-myeloproliferative-neoplasm-histology  | NZ WHO haematology chronic myeloproliferative neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-mzl-histology  | NZ WHO haematolymphoid marginal zone lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-plasma-cell-other-histology  | NZ WHO haematolymphoid plasma cell neoplasm and other diseases with paraproteins other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-primary-cns-lymphoma-histology  | NZ WHO haematolymphoid primary CNS lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-sll-histology  | NZ WHO haematolymphoid small lymphocytic lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-stroma-histology  | NZ WHO hematolymphoid stroma derived neoplasm of lymphoid tissue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-sys-mastocytosis-histology  | NZ WHO haematolymphoid systemic mastocytosis histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-t-nk-cell-histology  | NZ WHO hematolymphoid T cell and NK cell lymphoid proliferation or lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-haematology-t-nk-cell-other-histology  | NZ WHO haematolymphoid T-cell and natural killer cell neoplasm other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-benign-histology  | NZ WHO classification of tumours head and neck benign histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-ear-histology  | NZ WHO classification of tumours head and neck ear histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-germ-cell-histology  | NZ WHO classification of tumours head and neck germ cell tumour histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-haematolymphoid-histology  | NZ WHO classification of tumours head and neck haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-hyp-lyx-trach-pps-histology  | NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-hyp-lyx-trach-pps-primary-histology  | NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-hyp-lyx-trach-pps-site-histology  | NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-malignant-histology  | NZ WHO classification of tumours head and neck malignant histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-melanocytic-histology  | NZ WHO classification of tumours head and neck melanocytic histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-primary-histology  | NZ WHO classification of tumours head and neck nasal primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-site-histology  | NZ WHO classification of tumours head and neck nasal site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-skull-histology  | NZ WHO classification of tumours head and neck nasal and paranasal and skull base histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-skull-primary-histology  | NZ WHO classification of tumours head and neck nasal and paranasal and skull base primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasal-skull-site-histology  | NZ WHO classification of tumours head and neck nasal and paranasal and skull base site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasopharynx-histology  | NZ WHO classification of tumours head and neck nasopharynx histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-nasopharynx-site-histology  | NZ WHO classification of tumours head and neck nasopharynx site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-neuro-paragang-histology  | NZ WHO classification of tumours head and neck neuroendocrine neoplasm and paraganglioma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-odontogenic-maxfac-histology  | NZ WHO classification of tumours head and neck odontogenic and maxillofacial bone histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-odontogenic-maxfac-primary-histology  | NZ WHO classification of tumours head and neck odontogenic and maxillofacial bone primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-oral-cavity-histology  | NZ WHO classification of tumours head and neck oral cavity and mobile tongue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-oral-cavity-primary-histology  | NZ WHO classification of tumours head and neck oral cavity and mobile tongue primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-oropharynx-histology  | NZ WHO classification of tumours head and neck oropharynx histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-oropharynx-primary-histology  | NZ WHO classification of tumours head and neck oropharynx primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-pharynx-larynx-trachea-primary-histology  | NZ WHO classification of tumours head and neck pharynx and larynx and trachea primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-pharynx-larynx-trachea-site-histology  | NZ WHO classification of tumours head and neck pharynx and larynx and trachea site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-salivary-histology  | NZ WHO classification of tumours head and neck salivary gland histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-salivary-primary-histology  | NZ WHO classification of tumours head and neck salivary gland primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-salivary-site-histology  | NZ WHO classification of tumours head and neck salivary gland site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-soft-tissue-histology  | NZ WHO classification of tumours head and neck soft tissue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-head-neck-uncertain-histology  | NZ WHO classification of tumours head and neck uncertain behaviour histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-heart-primary-histology  | NZ WHO heart primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-histology-cll-histology  | NZ WHO haematolymphoid chronic lymphocytic leukaemia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-histology-plasmacytoid-dendritic-histology  | NZ WHO haematolymphoid plasmacytoid dendritic cell neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-histology  | NZ WHO histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-indolent-b-cell-lymphoma-other-histology  | NZ WHO haematolymphoid indolent B cell lymphoma other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-indolent-bcell-lymphoma-histology  | NZ WHO haematolymphoid indolent B cell lymphoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-indolent-nh-b-cell-lymphoma-other-histology  | NZ WHO haematolymphoid indolent non-hodgkin B cell lymphoma other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-kidney-primary-histology  | NZ WHO kidney primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lacrimal-drainage-system-primary-histology  | NZ WHO lacrimal drainage system primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lacrimal-gland-primary-histology  | NZ WHO lacrimal gland primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lacrimal-gland-site-histology  | NZ WHO lacrimal gland site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-liver-site-histology  | NZ WHO liver site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-low-high-diff-grade  | NZ WHO malignant low high (differentiation) grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lower-gastro-primary-histology  | NZ WHO lower gastrointestinal primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-lower-gastro-site-histology  | NZ WHO lower gastrointestinal site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-male-breast-primary-histology  | NZ WHO male breast primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-mature-tnk-cell-other-histology  | NZ WHO haematolymphoid mature T-cell and natural killer cell neoplasm other histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-mature-tnk-leukaemia-histology  | NZ WHO haematolymphoid mature T cell and natural killer cell leukeamia histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-melanoma-cns-primary-histology  | NZ WHO classification of CNS melanoma primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-melanoma-primary-histology  | NZ WHO classification of melanoma primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-meninges-primary-histology  | NZ WHO meninges primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-mo-histology  | NZ WHO medical oncology histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-net-non-endo-organ-primary-histology  | NZ WHO neuroendocrine tumour non neuroendocrine organ primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-neuroendo-non-endo-organ-histology  | NZ WHO neuroendocrine neoplasm non neuroendocrine organ histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-neuroendo-pancreas-histology  | NZ WHO neuroendocrine pancreas histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-neuroendo-pancreas-primary-histology  | NZ WHO neuroendocrine pancreas primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-neuroendocrine-grade  | NZ WHO neuroendocrine tumour grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-oesophagus-primary-histology  | NZ WHO oesophagus primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-orbit-histology  | NZ WHO orbit histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-orbit-primary-histology  | NZ WHO orbit primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-ovary-primary-histology  | NZ WHO ovary primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-ovary-site-histology  | NZ WHO ovary site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pancreas-primary-histology  | NZ WHO pancreas primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pancreas-site-histology  | NZ WHO pancreas site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-penis-primary-histology  | NZ WHO penis primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-penis-site-histology  | NZ WHO penis site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pericardium-primary-histology  | NZ WHO pericardium primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pericardium-site-histology  | NZ WHO pericardium site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-peritoneum-site-histology  | NZ WHO peritoneum site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-pleura-site-histology  | NZ WHO pleural site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-prostate-primary-histology  | NZ WHO prostate primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-prostate-site-histology  | NZ WHO prostate site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-sclera-primary-histology  | NZ WHO sclera primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-heamatolymphoid-histology  | NZ WHO classification of tumours skin haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-keratinocytic-epidermal-histology  | NZ WHO classification of tumours skin keratinocytic and epidermal histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-malignant-histology  | NZ WHO classification of tumours skin malignant histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-melanocytic-histology  | NZ WHO classification of tumours skin melanocytic neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-merkel-primary-histology  | NZ WHO classification of Merkel cell carcinoma primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-precursor-histology  | NZ WHO classification of tumours skin precursor histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-skin-squamous-primary-histology  | NZ WHO classification of squamous cell carcinoma primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-small-intestine-primary-histology  | NZ WHO small intestine primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-small-intestine-site-histology  | NZ WHO small intestine site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-soft-tissue-bone-undiff-sarcoma-histology  | NZ WHO soft tissue and bone undifferentiated small round cell sarcoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-soft-tissue-histology  | NZ WHO soft tissue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-soft-tissue-primary-histology  | NZ WHO soft tissue primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-soft-tissue-site-histology  | NZ WHO soft tissue site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-spinal-cord-site-histology  | NZ WHO spinal cord site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-stomach-primary-histology  | NZ WHO stomach primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testicular-adnexa-primary-histology  | NZ WHO testicular adnexa primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testicular-adnexa-site-histology  | NZ WHO testicular adnexa site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testis-primary-histology  | NZ WHO testis primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testis-site-histology  | NZ WHO testis site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-benign-histology  | NZ WHO thoracic benign histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-ectopic-thyroid-parathyroid-histology  | NZ WHO thoracic ectopic tumour of thyroid and parathyroid origin histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-haematolymphoid-histology  | NZ WHO thoracic haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-malignant-histology  | NZ WHO thoracic malignant histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-mesenchymal-histology  | NZ WHO thoracic mesenchymal thorax histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-neuroendocrine-grade  | NZ WHO thoracic neuroendocrine tumour grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-non-small-cell-lung-histology  | NZ WHO thoracic non small cell lung histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-pleura-pericardium-histology  | NZ WHO thoracic pleura and pericardium histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-precursor-histology  | NZ WHO thoracic precursor histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-primary-histology  | NZ WHO thoracic primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-thoracic-small-cell-lung-histology  | NZ WHO thoracic small cell lung histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-upper-gastro-primary-histology  | NZ WHO upper gastrointestinal primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-upper-gastro-site-histology  | NZ WHO upper gastrointestinal site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urethra-primary-histology  | NZ WHO urethra primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urethra-site-histology  | NZ WHO urethra site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-histology  | NZ WHO urinary and male genital histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-kidney-germ-cell-histology  | NZ WHO urinary and male genital kidney germ cell histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-kidney-histology  | NZ WHO urinary and male genital kidney histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-neuroendocrine-histology  | NZ WHO urinary and male genital neuroendocrine histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-primary-histology  | NZ WHO urinary and male genital primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-prostate-histology  | NZ WHO urinary and male genital prostate histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-testicular-adnexa-histology  | NZ WHO urinary and male genital testicular adnexa histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-testis-germ-cell-histology  | NZ WHO urinary and male genital testis germ cell histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-male-genital-testis-histology  | NZ WHO urinary and male genital testis histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urinary-system-site-histology  | NZ WHO urinary system site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-corpus-primary-histology  | NZ WHO uterine corpus primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-corpus-site-histology  | NZ WHO uterine corpus site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-ligament-site-histology  | NZ WHO uterine ligament site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uterine-primary-histology  | NZ WHO uterine primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-uveal-tract-site-histology  | NZ WHO uveal tract site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-vagina-site-histology  | NZ WHO vagina site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-vulva-primary-histology  | NZ WHO vulva primary histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-vulva-site-histology  | NZ WHO vulva site histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-aggressive-bcell-lymphoma-histology  | NZ WHO haematolymphoid aggressive cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-aggressive-nh-bcell-lymphoma-histology  | NZ WHO haematolymphoid aggressive non-Hodgkin B cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-bone-histology  | NZ WHO bone histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-behaviour-free-histology  | NZ WHO breast behaviour free histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-benign-histology  | NZ WHO breast benign histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-haematolymphoid-histology  | NZ WHO breast haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-histology  | NZ WHO breast histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-breast-nipple-histology  | NZ WHO breast tumour of nipple histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-choroid-plexus-histology  | NZ WHO central nervous system choroid plexus histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-cranial-paraspinal-nerve-histology  | NZ WHO central nervous system cranial and paraspinal nerve histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-embryonal-histology  | NZ WHO central nervous system embryonal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-germ-cell-histology  | NZ WHO central nervous system germ cell histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-glioma-glioneuronal-neuronal-histology  | NZ WHO central nervous system glioma and glioneuronal and neuronal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-haematolymphoid-histology  | NZ WHO central nervous system haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-pineal-histology  | NZ WHO central nervous system pineal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-cns-sellar-region-histology  | NZ WHO central nervous system sellar region histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-differentiation-grade  | NZ WHO (5th edition) malignant differentiation grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-anal-canal-histology  | NZ WHO digestive system anal canal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-appendix-histology  | NZ WHO digestive system appendix histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-benign-histology  | NZ WHO digestive system benign tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-colon-rectum-hormone-histology  | NZ WHO digestive system colon and rectum hormone producing tumor histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-germ-tumour-histology  | NZ WHO digestive system germ cell tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-haematolymphoid-histology  | NZ WHO digestive system haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-liver-intrahepatic-bile-duct-histology  | NZ WHO digestive system liver and intrahepatic bile duct histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-mesenchymal-histology  | NZ WHO digestive system mesenchymal histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-precursor-histology  | NZ WHO digestive system precursor tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-digestive-uncertain-histology  | NZ WHO digestive system uncertain behaviour tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-adrenal-histology  | NZ WHO endocrine and neuroendocrine adrenal gland histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-benign-histology  | NZ WHO endocrine and neuroendocrine benign histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-malignant-histology  | NZ WHO endocrine and neuroendocrine malignant histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-pituitary-histology  | NZ WHO endocrine and neuroendocrine pituitary gland histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-pituitary-net-histology  | NZ WHO pituitary neuroendocrine tumour primary histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-thyroid-histology  | NZ WHO endocrine and neuroendocrine thyroid gland histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-endo-neuroendo-uncertain-histology  | NZ WHO endocrine and neuroendocrine uncertain behaviour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-haematolymphoid-histology  | NZ WHO eye and orbit haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-histology  | NZ WHO eye and orbit histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-lacrimal-gland-histology  | NZ WHO eye and orbit lacrimal gland histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-optic-disc-nerve-histology  | NZ WHO eye and orbit optic disc and optic nerve histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-retina-neuroepithelium-histology  | NZ WHO eye and orbit retina and neuroepithelium histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-soft-tissue-bone-histology  | NZ WHO eye and orbit soft tissue and bone histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-eye-orbit-uncertain-borderline-histology  | NZ WHO eye and orbit uncertain and borderline histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-germ-cell-histology  | NZ WHO female genital germ cell histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-haematolymphoid-histology  | NZ WHO female genital haematolymphoid histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-neuroendocrine-histology  | NZ WHO female genital neuroendocrine histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-ovary-histology  | NZ WHO female genital ovary histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-peritoneum-histology  | NZ WHO female genital peritoneum histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-female-genital-vagina-histology  | NZ WHO female genital vagina histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-acute-leukaemia-amb-lineage-histology  | NZ WHO haematolymphoid acute leukaemia of mixed or ambiguous lineage histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-amyloidosis-histology  | NZ WHO haematolymphoid amyloidosis histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-b-cell-lymphoma-histology  | NZ WHO haematolymphoid B cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-b-cell-reactive-lymphoma-histology  | NZ WHO haematolymphoid reactive B-cell rich lymphoid proliferations which mimic lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-bl-histology  | NZ WHO haematolymphoid Burkitt lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-castleman-disorder-histology  | NZ WHO haematolymphoid Castleman disease histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-cml-histology  | NZ WHO haematolymphoid chronic myeloid leukaemia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-cutaneous-t-cell-lymphoma-histology  | NZ WHO haematolymphoid primary cutaneous T cell lymphoproliferative disorder histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-et-histology  | NZ WHO haematolymphoid essential thrombocythaemia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-extranod-nk-t-cell-lymphoma-histology  | NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-histiocytic-histology  | NZ WHO haematolymphoid histiocytic dendritic cell neoplasm histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-histology  | NZ WHO haematolymphoid tumour histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-intest-nk-t-cell-lymphoid-histology  | NZ WHO classification of tumours (5th edition) haematolymphoid intestinal T-cell and natural killer cell lymphoid proliferation histology reference set |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-leukaemia-histology  | NZ WHO haematolymphoid leukaemia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-lymphoplasmacytic-lymphoma-histology  | NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-mc-lymphoma-histology  | NZ WHO haematolymphoid mantle cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-mds-histology  | NZ WHO haematolymphoid myelodysplastic syndrome histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-mds-myeloproliferative-histology  | NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-myeloid-lymphoid-gene-histology  | NZ WHO haematolymphoid myeloid/lymphoid neoplasm with eosinophilia and defining gene rearrangement histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-myeloid-secondary-histology  | NZ WHO classification of tumours (5th edition) haematolymphoid secondary myeloid neoplasm histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-myeloproliferative-neoplasm-histology  | NZ WHO haematology chronic myeloproliferative neoplasm histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-nhl-histology  | NZ WHO haematolymphoid non Hodgkin lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-peripheral-t-cell-lymphoma-histology  | NZ WHO haematolymphoid peripheral T cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-plasma-cell-histology  | NZ WHO haematolymphoid plasma cell neoplasms and other diseases with paraproteins histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-haematology-pv-histology  | NZ WHO haematolymphoid polycythaemia vera histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-benign-histology  | NZ WHO classification of tumours (5th edition) head and neck benign histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-ear-histology  | NZ WHO classification of tumours (5th edition) head and neck ear histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-haematolymphoid-histology  | NZ WHO classification of tumours (5th edition) head and neck haematolymphoid histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-histology  | NZ WHO classification of tumours (5th edition) head and neck histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-malignant-histology  | NZ WHO classification of tumours (5th edition) head and neck malignant histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-melanocytic-histology  | NZ WHO classification of tumours (5th edition) head and neck melanocytic histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-nasal-skull-histology  | NZ WHO classification of tumours (5th edition) head and neck nasal and paranasal and skull base histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-nasopharynx-histology  | NZ WHO classification of tumours (5th edition) head and neck nasopharynx histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-neck-lymph-histology  | NZ WHO classification of tumours (5th edition) head and neck tumour and tumour-like lesion of the neck and lymph node histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-odontogenic-maxfac-histology  | NZ WHO classification of tumours (5th edition) head and neck odontogenic and maxillofacial bone histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-oral-cavity-histology  | NZ WHO classification of tumours (5th edition) head and neck oral cavity and mobile tongue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-pharynx-larynx-histology  | NZ WHO classification of tumours (5th edition) head and neck hypopharynx and larynx and trachea and parapharyngeal histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-precursor-histology  | NZ WHO classification of tumours (5th edition) head and neck precursor histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-salivary-histology  | NZ WHO classification of tumours (5th edition) head and neck salivary gland histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-head-neck-soft-tissue-histology  | NZ WHO classification of tumours (5th edition) head and neck soft tissue histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-histology-cll-histology  | NZ WHO haematolymphoid chronic lymphocytic leukaemia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-indolent-bcell-lymphoma-histology  | NZ WHO haematolymphoid indolent B cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-indolent-nh-bcell-lymphoma-histology  | NZ WHO haematolymphoid indolent non-Hodgkin B cell lymphoma histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-low-high-diff-grade  | NZ WHO (5th edition) malignant low high (differentiation) grade |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-mature-tnk-cell-histology  | NZ WHO haematolymphoid mature T cell and natural killer cell neoplasm histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-mature-tnk-leukaemia-histology  | NZ WHO haematolymphoid mature T cell and natural killer cell leukeamia histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-melanoma-cns-histology  | NZ WHO classification of tumours (5th edition) CNS melanoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-melanoma-histology  | NZ WHO classification of tumours (5th edition) melanoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-melanoma-mucosal-histology  | NZ WHO classification of tumours (5th edition) mucosal melanoma histology |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-monoclonal-b-cell-lymphocytosis-histology  | NZ WHO haematolymphoid monoclonal B cell lymphocytosis histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-net-non-endo-organ-histology  | NZ WHO neuroendocrine tumour non neuroendocrine organ primary histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-neuroendo-pancreas-histology  | NZ WHO neuroendocrine pancreas histology (5th edition) |
https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who5-neuroendo-pancreas-net-histology |